{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:11:28Z","timestamp":1791886288738,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd015363","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000}}],"reference-count":603,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015363.pub2","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T08:50:54Z","timestamp":1763974254000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination"],"prefix":"10.1002","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-2519","authenticated-orcid":false,"given":"Nicholas","family":"Henschke","sequence":"additional","affiliation":[{"name":"Cochrane Response; The Cochrane Collaboration; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Bergman","sequence":"additional","affiliation":[{"name":"Cochrane Response; The Cochrane Collaboration; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S","family":"Buckley","sequence":"additional","affiliation":[{"name":"Cochrane Response; The Cochrane Collaboration; London UK"},{"name":"Department of Surgery; University of the Philippines; Manila Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J","family":"Crosbie","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, Faculty of Biology, Medicine and Health; University of Manchester; Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Dwan","sequence":"additional","affiliation":[{"name":"Centre for Reviews and Dissemination; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su P","family":"Golder","sequence":"additional","affiliation":[{"name":"Department of Health Sciences; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kyrgiou","sequence":"additional","affiliation":[{"name":"IRDB, Department of Gut, Metabolism & Reproduction - Surgery & Cancer; Imperial College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Kong","family":"Loke","sequence":"additional","affiliation":[{"name":"Norwich Medical School; University of East Anglia; Norwich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M","family":"McIntosh","sequence":"additional","affiliation":[{"name":"Cochrane Response; The Cochrane Collaboration; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Probyn","sequence":"additional","affiliation":[{"name":"Cochrane Response; The Cochrane Collaboration; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Cochrane Response; The Cochrane Collaboration; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Morrison","sequence":"additional","affiliation":[{"name":"Department of Gynaecological Oncology; Musgrove Park Hospital; Taunton UK"},{"name":"Faculty of Health and Life Sciences; University of Exeter; Exeter, Devon UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"pkab086","DOI":"10.1093\/jncics\/pkab086","article-title":"Prevalence of oral human papillomavirus infection by number of vaccine doses among US adults","volume":"5","author":"Abel","year":"2021","journal-title":"JNCI Cancer Spectrum"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fcimb.2019.00059","article-title":"Changes in cervical human papillomavirus (HPV) prevalence at a youth clinic in Stockholm, Sweden, a decade after the introduction of the HPV vaccine","volume":"9","author":"Ahrlund-Richter","year":"2019","journal-title":"Frontiers in Cellular & Infection Microbiology"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-13-140","article-title":"Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program","volume":"13","author":"Ali","year":"2013","journal-title":"BMC Infectious Diseases"},{"issue":"13","key":"10.1002\/14651858.CD015363.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.vaccine.2017.01.076","article-title":"No increased risk of Guillain-Barre syndrome after human papilloma virus vaccine: a self-controlled case-series study in England","volume":"35","author":"Andrews","year":"2017","journal-title":"Vaccine"},{"issue":"7930","key":"10.1002\/14651858.CD015363.pub2-BIB0005|cit5","first-page":"f5906","article-title":"Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study","volume":"347","author":"Arnheim-Dahlstr\u00f6m","year":"2013","journal-title":"BMJ (online)"},{"issue":"41","key":"10.1002\/14651858.CD015363.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"e27457","DOI":"10.1097\/MD.0000000000027457","article-title":"Cervical cancer screening varies by HPV vaccination status among a national cohort of privately insured young women in the United States 2006-2016","volume":"100","author":"Ba","year":"2021","journal-title":"Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/OLQ.0b013e31827bd66b","article-title":"Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program","volume":"40","author":"Baandrup","year":"2013","journal-title":"Sexually Transmitted Diseases"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"E3220","DOI":"10.1093\/cid\/ciaa1067","article-title":"One-dose human papillomavirus vaccination and the risk of genital warts: a Danish nationwide population-based study","volume":"73","author":"Baandrup","year":"2021","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/cit436","article-title":"Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark","volume":"57","author":"Blomberg","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/civ364","article-title":"Dose-related differences in effectiveness of human papillomavirus vaccination against genital warts: a nationwide study of 550,000 young girls","volume":"61","author":"Blomberg","year":"2015","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/OLQ.0000000000000418","article-title":"Significant reduction in the incidence of genital warts in young men 5 years into the Danish human papillomavirus vaccination program for girls and women","volume":"43","author":"Bollerup","year":"2016","journal-title":"Sexually Transmitted Diseases"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jnci\/djad189","article-title":"Human papillomavirus vaccination and anal high-grade precancerous lesions and cancer - a real-world effectiveness study","volume":"116","author":"Baandrup","year":"2024","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2147\/CLEP.S203023","article-title":"Non-adherence to childhood HPV vaccination is associated with non-participation in cervical cancer screening - a nationwide Danish register-based cohort study","volume":"11","author":"Badre-Esfahani","year":"2019","journal-title":"Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10552-014-0392-4","article-title":"Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program","volume":"25","author":"Baldur-Felskov","year":"2014","journal-title":"Cancer Causes & Control"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"djt460","DOI":"10.1093\/jnci\/djt460","article-title":"Early impact of human papillomavirus vaccination on cervical neoplasia -- nationwide follow-up of young Danish women","volume":"106","author":"Baldur-Felskov","year":"2014","journal-title":"Journal of the National Cancer Institute"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s10552-015-0603-7","article-title":"Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997-2012","volume":"26","author":"Baldur-Felskov","year":"2015","journal-title":"Cancer Causes & Control"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/ijc.34328","article-title":"Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: population impact of multi-cohort vaccination against human papillomavirus infection","volume":"152","author":"Ring","year":"2023","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0018|cit18","doi-asserted-by":"crossref","unstructured":"Balgovind P Aung E Shilling H Murray GL Molano M Garland SM Human papillomavirus prevalence among Australian men aged 18-35 years in 2015-2018 according to vaccination status and sexual preference Journal of Infectious Diseases 2024 231 2 jiae412 10.1093\/infdis\/jiae412","DOI":"10.1093\/infdis\/jiae412"},{"issue":"48","key":"10.1002\/14651858.CD015363.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1016\/j.vaccine.2015.07.024","article-title":"Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16\/18 AS04-adjuvanted vaccine in the United Kingdom","volume":"33","author":"Baril","year":"2015","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"100175","DOI":"10.1016\/j.pvr.2019.100175","article-title":"HPV genoprevalence and HPV knowledge in young women in Mongolia, five years following a pilot 4vHPV vaccination campaign","volume":"8","author":"Batmunkh","year":"2019","journal-title":"Papillomavirus Research"},{"issue":"27","key":"10.1002\/14651858.CD015363.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1016\/j.vaccine.2020.04.041","article-title":"A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination","volume":"38","author":"Batmunkh","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","article-title":"Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010","volume":"102","author":"Bauer","year":"2012","journal-title":"American Journal of Public Health"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/M20-2849","article-title":"Prevalence of human papillomavirus and estimation of human papillomavirus vaccine effectiveness in Thimphu, Bhutan, in 2011\u20132012 and 2018: a cross-sectional study","volume":"173","author":"Baussano","year":"2020","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2701.191364","article-title":"Impact of human papillomavirus vaccination, Rwanda and Bhutan","volume":"27","author":"Baussano","year":"2021","journal-title":"Emerging Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1542\/peds.2012-1516","article-title":"Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds","volume":"130","author":"Bednarczyk","year":"2012","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jamaoncol.2024.2673","article-title":"Population-based incidence of cervical intraepithelial neoplasia across 14 years of HPV vaccination","volume":"10","author":"Adcock","year":"2024","journal-title":"JAMA Oncology"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamaoncol.2016.3609","article-title":"Population-based incidence rates of cervical intraepithelial neoplasia in the human papillomavirus vaccine era","volume":"3","author":"Benard","year":"2017","journal-title":"JAMA Oncology"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cid\/ciab605","article-title":"Prevalence of oral human papillomavirus infection: impact of sex, race\/ethnicity and vaccination status","volume":"74","author":"Berenson","year":"2021","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ygyno.2020.05.683","article-title":"Time trends in the incidence and survival of vaginal squamous cell carcinoma and high-grade vaginal intraepithelial neoplasia in Denmark - a nationwide population-based study","volume":"158","author":"Bertoli","year":"2020","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/pathogens13030209","article-title":"Human papillomavirus (HPV) infection and risk behavior in vaccinated and non-vaccinated Paraguayan young women","volume":"13","author":"Bobadilla","year":"2024","journal-title":"Pathogens"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/infdis\/jiz280","article-title":"Bivalent human papillomavirus (HPV) vaccine effectiveness correlates with phylogenetic distance from HPV vaccine types 16 and 18","volume":"220","author":"Bogaards","year":"2019","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/infdis\/jix582","article-title":"Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors","volume":"217","author":"Woestenberg","year":"2018","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jinf.2017.01.007","article-title":"No evidence for cross-protection of the HPV-16\/18 vaccine against HPV-6\/11 positivity in female STI clinic visitors","volume":"74","author":"Woestenberg","year":"2017","journal-title":"Journal of Infection"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.canep.2016.04.003","article-title":"Associations between prior HPV4 vaccine doses and cervical cancer screening participation","volume":"42","author":"Boone","year":"2016","journal-title":"Cancer Epidemiology"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"100177","DOI":"10.1016\/j.pvr.2019.100177","article-title":"Is one dose of human papillomavirus vaccine as effective as three? A national cohort analysis","volume":"8","author":"Brotherton","year":"2019","journal-title":"Papillomavirus Research"},{"issue":"9783","key":"10.1002\/14651858.CD015363.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pvr.2015.05.005","article-title":"Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: observational cohort of young women in Australia","volume":"1","author":"Brotherton","year":"2015","journal-title":"Papillomavirus Research"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10552-015-0568-6","article-title":"Human papillomavirus vaccination is changing the epidemiology of high-grade cervical lesions in Australia","volume":"26","author":"Brotherton","year":"2015","journal-title":"Cancer Causes & Control"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1741-7015-11-227","article-title":"Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study","volume":"11","author":"Gertig","year":"2013","journal-title":"BMC Medicine"},{"issue":"37","key":"10.1002\/14651858.CD015363.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1016\/j.vaccine.2020.06.073","article-title":"Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy","volume":"38","author":"Bukowinski","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/imj.13005","article-title":"Adverse event monitoring of the human papillomavirus vaccines in Scotland","volume":"46","author":"Cameron","year":"2016","journal-title":"Internal Medicine Journal"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/sextrans-2016-052626","article-title":"Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16\/18) vaccination programme in England: an ecological analysis","volume":"93","author":"Canvin","year":"2017","journal-title":"Sexually Transmitted Infections"},{"issue":"32","key":"10.1002\/14651858.CD015363.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1016\/j.vaccine.2021.06.040","article-title":"Reduction of HPV16\/18 prevalence in young women after eight years of three- and two-dose vaccination schemes","volume":"39","author":"Carnalla","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12879-018-2945-8","article-title":"Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy","volume":"18","author":"Carozzi","year":"2018","journal-title":"BMC Infectious Diseases"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ypmed.2018.10.001","article-title":"Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results","volume":"118","author":"Castle","year":"2019","journal-title":"Preventive Medicine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"e1039","DOI":"10.1093\/infdis\/jiae345","article-title":"Prevalence of oral human papillomavirus infection among urban gay, bisexual, and other men who have sex with men in Canada, 2017\u20132019","volume":"230","author":"Alessandrini","year":"2024","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/OLQ.0000000000001560","article-title":"Anal human papillomavirus prevalence among vaccinated and unvaccinated gay, bisexual, and other men who have sex with men in Canada","volume":"49","author":"Chambers","year":"2022","journal-title":"Sexually Transmitted Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/infdis\/jiad005","article-title":"Vaccine effectiveness against 12-month incident and persistent anal human papillomavirus infection among gay, bisexual, and other men who have sex with men","volume":"228","author":"Chambers","year":"2023","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"e2024040","DOI":"10.4178\/epih.e2024040","article-title":"Effect of the human papillomavirus vaccine on the risk of genital warts: a nationwide cohort study of Korean adolescent girls","volume":"46","author":"Cho","year":"2024","journal-title":"Epidemiology and Health"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(16)30116-5","article-title":"Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study","volume":"17","author":"Chow","year":"2017","journal-title":"Lancet Infectious Diseases"},{"issue":"46","key":"10.1002\/14651858.CD015363.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.1016\/j.vaccine.2019.09.052","article-title":"Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017","volume":"37","author":"Chow","year":"2019","journal-title":"Vaccine"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1473-3099(20)30687-3","article-title":"Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study","volume":"21","author":"Chow","year":"2021","journal-title":"Lancet Infectious Diseases"},{"issue":"7907","key":"10.1002\/14651858.CD015363.pub2-BIB0053|cit53","first-page":"f2032. Erratum","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","volume":"346","author":"Ali","year":"2013","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5694\/mja16.00597","article-title":"Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data","volume":"206","author":"Ali","year":"2017","journal-title":"Medical Journal of Australia"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S1473-3099(21)00071-2","article-title":"Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18","volume":"21","author":"Chow","year":"2021","journal-title":"Lancet Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/sextrans-2014-051813","article-title":"Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme","volume":"91","author":"Chow","year":"2015","journal-title":"Sexually Transmitted Infections"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":"Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/sti.2009.037788","article-title":"Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women","volume":"85","author":"Fairley","year":"2009","journal-title":"Sexually Transmitted Infections"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"100251","DOI":"10.1016\/j.lanwpc.2021.100251","article-title":"Genital warts trends in Australian and overseas-born people in Australia: a cross-sectional trend analysis to measure progress towards control and elimination","volume":"16","author":"Khawar","year":"2021","journal-title":"Lancet Regional Health - Western Pacific"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme","volume":"87","author":"Read","year":"2011","journal-title":"Sexually Transmitted Infections"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"106641","DOI":"10.1016\/j.ypmed.2021.106641","article-title":"The impact of a universal human papilloma virus (HPV) vaccination program on lower genital tract dysplasia and genital warts","volume":"150","author":"Clark","year":"2021","journal-title":"Preventive Medicine"},{"issue":"52","key":"10.1002\/14651858.CD015363.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"8396","DOI":"10.1016\/j.vaccine.2020.10.033","article-title":"Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: a population survey-based cross-sectional analysis","volume":"38","author":"Closson","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12879-017-2361-5","article-title":"Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: an observational study","volume":"17","author":"Cocchio","year":"2017","journal-title":"BMC Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1940-6207.CAPR-21-0063","article-title":"Reduction in vaccine HPV type infections in a young women group (18\u201325 years) five years after HPV vaccine introduction in Colombia","volume":"15","author":"Combita","year":"2021","journal-title":"Cancer Prevention Research (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0065|cit65","first-page":"g1458","article-title":"Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia","volume":"348","author":"Crowe","year":"2014","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/1471-0528.14562","article-title":"Reduction in colposcopy workload and associated clinical activity following human papillomavirus (HPV) catch-up vaccination programme in Scotland: an ecological study","volume":"124","author":"Cruickshank","year":"2017","journal-title":"BJOG"},{"issue":"37","key":"10.1002\/14651858.CD015363.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1016\/j.vaccine.2012.06.057","article-title":"Reduction of HPV infections through vaccination among at-risk urban adolescents","volume":"30","author":"Cummings","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41416-023-02386-9","article-title":"The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland","volume":"129","author":"Cuschieri","year":"2023","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/14760584.2018.1388168","article-title":"Absence of association between Guillain-Barre syndrome hospitalizations and HPV-vaccine","volume":"17","author":"Deceuninck","year":"2018","journal-title":"Expert Review of Vaccines"},{"issue":"43","key":"10.1002\/14651858.CD015363.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1016\/j.vaccine.2018.09.011","article-title":"Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions","volume":"36","author":"Dehlendorff","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2334-14-87","article-title":"Human papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling","volume":"14","author":"Delere","year":"2014","journal-title":"BMC Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/v13030486","article-title":"A retrospective cohort study of young women spontaneously choosing to be vaccinated against HPV: outcomes from their first cervical cancer screening test","volume":"13","author":"Del Mistro","year":"2021","journal-title":"Viruses"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0073|cit73","doi-asserted-by":"crossref","unstructured":"DeSisto CL Winer RL Querec TD Dada D Pathela P Asbel L Vaccine effectiveness against anal HPV among men who have sex with men aged 18-45 years attending sexual health clinics in three United States cities, 2018-2023 Journal of Infectious Diseases 2024 231 3 jiae394 10.1093\/infdis\/jiae394","DOI":"10.1093\/infdis\/jiae394"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/ijc.34517","article-title":"Oral human papillomavirus (HPV) infection and HPV vaccination in an Australian cohort","volume":"153","author":"De Souza","year":"2023","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"26","key":"10.1002\/14651858.CD015363.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1016\/j.vaccine.2018.05.019","article-title":"Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs","volume":"36","author":"Dillner","year":"2018","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"e0132404","DOI":"10.1371\/journal.pone.0132404","article-title":"Evaluating the early benefit of quadrivalent HPV vaccine on genital warts in Belgium: a cohort study","volume":"10","author":"Dominiak-Felden","year":"2015","journal-title":"PLoS ONE"},{"issue":"43","key":"10.1002\/14651858.CD015363.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1016\/j.vaccine.2013.08.024","article-title":"Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK","volume":"31","author":"Donegan","year":"2013","journal-title":"Vaccine"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/infdis\/jiy067","article-title":"High effectiveness of the bivalent human papillomavirus (HPV) vaccine against incident and persistent HPV infections up to 6 years after vaccination in young Dutch women","volume":"217","author":"Donken","year":"2018","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.vaccine.2022.11.057","article-title":"High vaccine effectiveness persists for ten years after HPV16\/18 vaccination among young Dutch women","volume":"41","author":"Hoes","year":"2023","journal-title":"Vaccine"},{"issue":"23","key":"10.1002\/14651858.CD015363.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1016\/j.vaccine.2015.04.016","article-title":"Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: results from a longitudinal Dutch cohort study","volume":"33","author":"Mollers","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"e0212927","DOI":"10.1371\/journal.pone.0212927","article-title":"Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females","volume":"14","author":"Van der Weele","year":"2019","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015363.pub2-BIB0082|cit82","first-page":"A349","article-title":"Effectiveness of the quadrivalent HPV vaccine against HSIL and CIN: a data-linkage study","volume":"95","author":"Donken","year":"2019","journal-title":"Sexually Transmitted Infections"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ijc.33513","article-title":"Declining rates of cervical intraepithelial neoplasia in British Columbia, Canada: an ecological analysis on the effects of the school-based human papillomavirus vaccination program","volume":"149","author":"Donken","year":"2021","journal-title":"International Journal of Cancer"},{"issue":"36","key":"10.1002\/14651858.CD015363.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1016\/j.vaccine.2021.07.009","article-title":"High-risk HPV prevalence among women undergoing cervical cancer screening: findings a decade after HPV vaccine implementation in British Columbia, Canada","volume":"39","author":"Litwin","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/ijc.29508","article-title":"Reduction in cervical intraepithelial neoplasia in young women in British Columbia after introduction of the HPV vaccine: an ecological analysis","volume":"137","author":"Ogilvie","year":"2015","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/infdis\/jiz422","article-title":"Cervical intraepithelial neoplasia rates in British Columbia women: a population-level data linkage evaluation of the school-based HPV immunization program","volume":"221","author":"Racey","year":"2020","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/AOG.0000000000001011","article-title":"Comparing cervical cytology and histology among human papillomavirus-vaccinated and -unvaccinated women in an academic colposcopy clinic","volume":"126","author":"Dorton","year":"2015","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"e0264821","DOI":"10.1371\/journal.pone.0264821","article-title":"Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France","volume":"17","author":"Elies","year":"2022","journal-title":"PloS ONE"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"e0223612","DOI":"10.1371\/journal.pone.0223612","article-title":"An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway","volume":"14","author":"Enerly","year":"2019","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.vaccine.2018.11.030","article-title":"Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy","volume":"37","author":"Faber","year":"2019","journal-title":"Vaccine"},{"issue":"10316","key":"10.1002\/14651858.CD015363.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"e077341","DOI":"10.1136\/bmj-2023-077341","article-title":"Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study","volume":"385","author":"Falcaro","year":"2024","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1089\/jwh.2018.7340","article-title":"Correlates of human papillomavirus vaccination and association with HPV-16 and HPV-18 DNA detection in young women","volume":"28","author":"Feder","year":"2019","journal-title":"Journal of Women's Health"},{"issue":"33","key":"10.1002\/14651858.CD015363.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2017.06.031","article-title":"HPV vaccination and risk of chronic fatigue syndrome\/myalgic encephalomyelitis: a nationwide register-based study from Norway","volume":"35","author":"Feiring","year":"2017","journal-title":"Vaccine"},{"issue":"51","key":"10.1002\/14651858.CD015363.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1016\/j.vaccine.2017.09.041","article-title":"No conflicting results in the article \"HPV vaccination and risk of chronic fatigue syndrome\/myalgic encephalomyelitis: a nationwide register-based study from Norway\"","volume":"35","author":"Feiring","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.vaccine.2021.11.070","article-title":"Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: a retrospective, chart review study","volume":"40","author":"Fernandes","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2105\/AJPH.2012.301182","article-title":"Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination","volume":"103","author":"Flagg","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2105\/AJPH.2017.304119","article-title":"Declines in anogenital warts among age groups most likely to be impacted by human papillomavirus vaccination, United States, 2006-2014","volume":"108","author":"Flagg","year":"2018","journal-title":"American Journal of Public Health"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD015363.pub2-BIB0099|cit99","first-page":"A39","article-title":"Population effectiveness of human papillomavirus vaccination against anogenital warts among female enrollees in private health plans in the united states, 2006-2014","volume":"93","author":"Flagg","year":"2017","journal-title":"Sexually Transmitted Infections"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/ije\/dyx273","article-title":"Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism","volume":"47","author":"Frisch","year":"2018","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/1055-9965.EPI-21-0625","article-title":"An evaluation of dose-related HPV vaccine effectiveness using central registries in Michigan","volume":"31","author":"Gargano","year":"2021","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ijc.34231","article-title":"HPV type-specific trends in cervical precancers in the United States, 2008 to 2016","volume":"152","author":"Gargano","year":"2023","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"23","key":"10.1002\/14651858.CD015363.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.vaccine.2018.04.080","article-title":"Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program","volume":"36","author":"Garland","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/21645515.2017.1385688","article-title":"Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada","volume":"14","author":"Goggin","year":"2018","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"100208","DOI":"10.1016\/j.pvr.2020.100208","article-title":"Strong reduction in prevalence of HPV16\/18 and closely related HPV types in sexually active adolescent women following the introduction of HPV vaccination in Argentina","volume":"10","author":"Gonzalez","year":"2020","journal-title":"Papillomavirus Research"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1007\/s00404-024-07692-y","article-title":"The impact of Germany's human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances","volume":"310","author":"Goodman","year":"2024","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"13","key":"10.1002\/14651858.CD015363.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3238\/arztebl.m2024.0062","article-title":"Initial evidence of a possible effect of HPV vaccination on cancer incidence in Germany","volume":"121","author":"Grieger","year":"2024","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2017.01.005","article-title":"Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: six years of case-referent surveillance","volume":"79","author":"Grimaldi-Bensouda","year":"2017","journal-title":"Journal of Autoimmunity"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/joim.12535","article-title":"Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study","volume":"280","author":"Gronlund","year":"2016","journal-title":"Journal of Internal Medicine"},{"issue":"39","key":"10.1002\/14651858.CD015363.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1016\/j.vaccine.2016.08.020","article-title":"Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): a population-based assessment","volume":"34","author":"Guerra","year":"2016","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015363.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"93S","DOI":"10.1097\/01.AOG.0000825608.02433.2d","article-title":"Human papillomavirus (HPV) vaccine effect on incidence of in situ and invasive squamous cell cancer of the vulva, 2001-2018","volume":"139","author":"Berenson","year":"2022","journal-title":"Obstetrics & Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1158\/1940-6207.CAPR-22-0086","article-title":"Vulvar cancer incidence in the United States and its relationship to human papillomavirus vaccinations, 2001-2018","volume":"15","author":"Berenson","year":"2022","journal-title":"Cancer Prevention Research (Philadelphia, Pa.)"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0113|cit113","doi-asserted-by":"crossref","unstructured":"Berenson AB Guo F Chang M Association of human papillomavirus vaccination with the incidence of squamous cell carcinomas of the anus in the US JAMA Oncology 2022 8 4 10.1001\/jamaoncol.2021.7652","DOI":"10.1001\/jamaoncol.2021.7652"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1136\/ijgc-2022-003728","article-title":"The increasing incidence of stage IV cervical cancer in the USA: what factors are related?","volume":"32","author":"Francoeur","year":"2022","journal-title":"International Journal of Gynecological Cancer"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"pkad016","DOI":"10.1093\/jncics\/pkad016","article-title":"Incidence of human papillomavirus-related cancers among males and females aged 15-34 years in the United States","volume":"7","author":"Guo","year":"2023","journal-title":"JNCI Cancer Spectrum"},{"issue":"7 Suppl","key":"10.1002\/14651858.CD015363.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"S450","DOI":"10.1016\/j.jval.2022.04.834","article-title":"EPH82 impact of HPV vaccination on cervical cancer incidence among females 15-34 years old, 2001-2018","volume":"25","author":"Guo","year":"2022","journal-title":"Value in Health"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.amepre.2018.03.013","article-title":"Cervical cancer incidence in young U.S. females after human papillomavirus vaccine introduction","volume":"55","author":"Guo","year":"2018","journal-title":"American Journal of Preventive Medicine"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"e222530","DOI":"10.1001\/jamanetworkopen.2022.2530","article-title":"Trends in human papillomavirus-associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017","volume":"5","author":"Francoeur","year":"2022","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1055-9965.EPI-20-0846","article-title":"Assessing impact of HPV vaccination on cervical cancer incidence among women aged 15-29 years in the United States, 1999-2017: an ecologic study","volume":"30","author":"Mix","year":"2021","journal-title":"Cancer Epidemiology Biomarkers and Prevention"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/aje\/kwx253","article-title":"Human papillomavirus vaccine effectiveness against incident genital warts among female health-plan enrollees, United States","volume":"187","author":"Hariri","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"e105967","DOI":"10.1371\/journal.pone.0105967","article-title":"Decreased management of genital warts in young women in Australian general practice post introduction of national HPV vaccination program: results from a nationally representative cross-sectional general practice study","volume":"9","author":"Harrison","year":"2014","journal-title":"PloS ONE"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0122|cit122","first-page":"757","article-title":"Effectiveness of human papillomavirus vaccination on prevalence of vaccine genotypes in young sexually active women in France","volume":"215","author":"Heard","year":"2017","journal-title":"Journal of Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1002\/ijc.30035","article-title":"Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: a population-based study","volume":"138","author":"Herweijer","year":"2016","journal-title":"International Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/jama.2014.95","article-title":"Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma","volume":"311","author":"Herweijer","year":"2014","journal-title":"JAMA"},{"issue":"15","key":"10.1002\/14651858.CD015363.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.vaccine.2018.02.097","article-title":"Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden","volume":"36","author":"Herweijer","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/infdis\/jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability","volume":"206","author":"Leval","year":"2012","journal-title":"Journal of Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jnci\/djt032","article-title":"Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study","volume":"105","author":"Leval","year":"2013","journal-title":"Journal of the National Cancer Institute"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/jog.15270","article-title":"The difference in the effectiveness of human papillomavirus vaccine based on smoking status","volume":"48","author":"Hikari","year":"2022","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/jog.15530","article-title":"The difference in the effectiveness of HPV vaccine based on smoking status","volume":"49","author":"Takako","year":"2023","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0130|cit130","first-page":"1","article-title":"The efficacy of human papillomavirus vaccination in young Japanese girls: the interim results of the OCEAN study","volume":"18","author":"Hiramatsu","year":"2021","journal-title":"Human Vaccines and Immunotherapeutics"},{"issue":"27","key":"10.1002\/14651858.CD015363.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1016\/j.vaccine.2017.05.025","article-title":"Prevalence of oral human papillomavirus by vaccination status among young adults (18-30 years old)","volume":"35","author":"Hirth","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/infdis\/jiab250","article-title":"Vaccine effectiveness following routine immunization with bivalent human papillomavirus (HPV) vaccine: protection against incident genital HPV infections from a reduced-dosing schedule","volume":"226","author":"Hoes","year":"2022","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/infdis\/jiab250","article-title":"Vaccine effectiveness following routine immunization with bivalent HPV vaccine: protection against incident genital HPV infections from a reduced-dosing schedule","volume":"226","author":"Hoes","year":"2021","journal-title":"Journal of Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/infdis\/jit361","article-title":"Declining genital warts in young women in England associated with HPV 16\/18 vaccination: an ecological study","volume":"208","author":"Howell-Jones","year":"2013","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/CEJ.0000000000000761","article-title":"Evolution of human papillomavirus prevalence in a highly vaccinated region in Belgium: a retrospective cohort study in Flemish women (2010-2019)","volume":"32","author":"Huyghe","year":"2023","journal-title":"European Journal of Cancer Prevention"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/joim.12694","article-title":"Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases","volume":"283","author":"Hviid","year":"2017","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0137|cit137","first-page":"m2930","article-title":"Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis","volume":"370","author":"Hviid","year":"2020","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"e2120391","DOI":"10.1001\/jamanetworkopen.2021.20391","article-title":"Association between human papillomavirus vaccination and primary ovarian insufficiency in a nationwide cohort","volume":"4","author":"Hviid","year":"2021","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/cas.14682","article-title":"Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: a nationwide case-control study","volume":"112","author":"Ikeda","year":"2021","journal-title":"Cancer Science"},{"issue":"1508","key":"10.1002\/14651858.CD015363.pub2-BIB0140|cit140","first-page":"72","article-title":"Impact of human papillomavirus vaccination on rates of abnormal cervical cytology and histology in young New Zealand women","volume":"133","author":"Innes","year":"2020","journal-title":"New Zealand Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1186\/s12879-017-2867-x","article-title":"Impact of HPV vaccination with Gardasil R in Switzerland","volume":"17","author":"Jacot-Guillarmod","year":"2017","journal-title":"BMC Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/ijerph15071447","article-title":"Prevalence of vaccine type infections in vaccinated and non-vaccinated young women: HPV-IMPACT, a self-sampling study","volume":"15","author":"Jeannot","year":"2018","journal-title":"International Journal of Environmental Research & Public Health"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"926555","DOI":"10.3389\/fonc.2022.926555","article-title":"Trends in oropharyngeal cancer incidence among adult men and women in the United States from 2001 to 2018","volume":"12","author":"Guo","year":"2022","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels","volume":"105","author":"Jemal","year":"2013","journal-title":"Journal of the National Cancer Institute"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/healthcare10071211","article-title":"Trends in the utilization of human papillomavirus vaccines and the incidence of malignant cervical cancer in women and teenagers: a secondary analysis","volume":"10","author":"Luna","year":"2022","journal-title":"Healthcare (Basel, Switzerland)"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"998174","DOI":"10.3389\/fpubh.2022.998174","article-title":"Impact of human papillomavirus vaccine on cervical cancer epidemic: evidence from the Surveillance, Epidemiology, and End Results Program","volume":"10","author":"Pei","year":"2022","journal-title":"Frontiers in Public Health"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015363.pub2-BIB0147|cit147","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1016\/S0090-8258%2822%2901565-7","article-title":"Long-term trends in cervical cancer: incidence rates and impact of human papillomavirus testing and vaccination in the United States (343)","volume":"166","author":"Semanaz","year":"2022","journal-title":"Gynecologic Oncology"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jamainternmed.2014.7886","article-title":"Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females","volume":"175","author":"Jena","year":"2015","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1071\/SH14218","article-title":"Potential impact of the human papillomavirus vaccine on the incidence proportion of genital warts in French women (EFFICAE study): a multicentric prospective observational study","volume":"13","author":"Judlin","year":"2016","journal-title":"Sexual Health"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1542\/peds.2011-3587","article-title":"Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction","volume":"130","author":"Kahn","year":"2012","journal-title":"Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/cid\/ciw533","article-title":"Substantial decline in vaccine-type human papillomavirus (HPV) among vaccinated young women during the first 8 years after HPV vaccine introduction in a community","volume":"63","author":"Kahn","year":"2016","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"106473","DOI":"10.1016\/j.ypmed.2021.106473","article-title":"Preterm birth rate after bivalent HPV vaccination: registry-based follow-up of a randomized clinical trial","volume":"146","author":"Kalliala","year":"2021","journal-title":"Preventive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jop.13091","article-title":"The impact of HPV vaccination on the prevalence of oropharyngeal cancer (OPC) in a hospital-based population: a cross-sectional study of patient's registry","volume":"50","author":"Katz","year":"2021","journal-title":"Journal of Oral Pathology & Medicine"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"e0278477","DOI":"10.1371\/journal.pone.0278477","article-title":"Changes in genital human papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program","volume":"17","author":"Khoo","year":"2022","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/v15010159","article-title":"Prevalence of human papillomavirus types 16\/18 and effect of vaccination among Japanese female general citizens in the vaccine crisis era","volume":"15","author":"Kitamura","year":"2023","journal-title":"Viruses"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/cid\/cix797","article-title":"A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries","volume":"66","author":"Kjaer","year":"2018","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"100401","DOI":"10.1016\/j.eclinm.2020.100401","article-title":"Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four Nordic countries","volume":"23","author":"Kjaer","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-world effectiveness of human papillomavirus vaccination against cervical cancer","volume":"113","author":"Kjaer","year":"2021","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/21645515.2020.1839292","article-title":"Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up","volume":"17","author":"Kjaer","year":"2021","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.18565\/aig.2020.1.146-154","article-title":"The features of the course of pregnancy and its outcomes in women vaccinated against papillomavirus infection","volume":"2020","author":"Krasnopolsky","year":"2020","journal-title":"Akusherstvo I Ginekologiya (Russian Federation)"},{"issue":"18","key":"10.1002\/14651858.CD015363.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.vaccine.2015.03.015","article-title":"Rationale and design of a long term follow-up study of women who did and did not receive HPV 16\/18 vaccination in Guanacaste, Costa Rica","volume":"33","author":"Costa Rica HPV Vaccine Trial Group","year":"2015","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0162|cit162","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/jnci\/djac107","article-title":"Performance of cervical screening a decade following HPV vaccination: the Costa Rica vaccine trial","volume":"114","author":"on behalf of the Costa\u202fRica HPV Vaccine Trial (CVT) Group","year":"2022","journal-title":"Journal of the National Cancer Institute"},{"issue":"19","key":"10.1002\/14651858.CD015363.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/jnci\/djr319","article-title":"Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16\/18 vaccine","volume":"103","author":"Kreimer","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/jnci\/djaa011","article-title":"Evaluation of durability of a single dose of the bivalent HPV vaccine: the CVT trial","volume":"112","author":"Kreimer","year":"2020","journal-title":"Journal of the National Cancer Institute"},{"issue":"32 Pt A","key":"10.1002\/14651858.CD015363.pub2-BIB0165|cit165","first-page":"4774","article-title":"Evidence for single-dose protection by the bivalent HPV vaccine - review of the Costa Rica HPV vaccine trial and future research studies","volume":"36","year":"2018","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0166|cit166","first-page":"h4358","article-title":"Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial","volume":"351","author":"Costa Rica HPV Vaccine Trial (CVT) Group","year":"2015","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S1470-2045(20)30524-6","article-title":"Efficacy of the bivalent HPV vaccine against HPV 16\/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial","volume":"21","author":"Porras","year":"2020","journal-title":"Lancet Oncology"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S1470-2045(20)30524-6","article-title":"Efficacy of the bivalent HPV vaccine against HPV 16\/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial","volume":"21","author":"Porras","year":"2020","journal-title":"Lancet Oncology"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/djx158","article-title":"Durability of protection afforded by fewer doses of the HPV16\/18 vaccine: the CVT trial","volume":"110","author":"for the Costa Rica HPV Vaccine Trial (CVT) Group","year":"2018","journal-title":"Journal of the National Cancer Institute"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0170|cit170","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S1470-2045(22)00291-1","article-title":"Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial","volume":"23","author":"Costa\u202fRica\u202fHPV \u202fVaccine\u202fTrial\u202f(CVT)\u202fGroup","year":"2022","journal-title":"Lancet Oncology"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jnci\/djaa010","article-title":"Durability of cross-protection by different schedules of the bivalent HPV vaccine: the CVT trial","volume":"112","year":"2020","journal-title":"Journal of the National Cancer Institute"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1111\/cas.15471","article-title":"Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: multivariate analyses adjusted for sexual activity","volume":"113","author":"Kudo","year":"2022","journal-title":"Cancer Science"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/infdis\/jiy516","article-title":"Bivalent human papillomavirus vaccine effectiveness in a Japanese population: high vaccine-type-specific effectiveness and evidence of cross-protection","volume":"219","author":"Kudo","year":"2019","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD015363.pub2-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"A76","DOI":"10.1136\/ijgc-2022-igcs.159","article-title":"Long-term effect of HPV vaccination against HPV infection in Japanese young women","volume":"32","author":"Kurosawa","year":"2022","journal-title":"International Journal of Gynecological Cancer"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0175|cit175","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1111\/cas.15282","article-title":"Long-term effectiveness of HPV vaccination against HPV infection in young Japanese women: real-world data","volume":"113","author":"Kurosawa","year":"2022","journal-title":"Cancer Science"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines8030425","article-title":"Epidemiologic profile of type-specific human papillomavirus infection after initiation of HPV vaccination","volume":"8","author":"Sekine","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12905-017-0394-y","article-title":"Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among bivalent human papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study","volume":"17","author":"Kumakech","year":"2017","journal-title":"BMC Women's Health"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"e0160099","DOI":"10.1371\/journal.pone.0160099","article-title":"Significantly reduced genoprevalence of vaccine-type HPV-16\/18 infections among vaccinated compared to non-vaccinated young women 5.5 years after a bivalent HPV-16\/18 vaccine (Cervarix R) pilot project in Uganda","volume":"11","author":"Kumakech","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trivac.2013.08.001","article-title":"Implementation of the quadrivalent vaccine against HPV in the Municipality of Campos dos Goytacazes, Brazil - a combination of strategies to increase immunization coverage and early reduction of genital warts","volume":"2","author":"Kury","year":"2013","journal-title":"Trials in Vaccinology"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/infdis\/jiy432","article-title":"Substantial decline in prevalence of vaccine-type and nonvaccine-type human papillomavirus (HPV) in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway","volume":"218","author":"Feiring","year":"2018","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/infdis\/jiaa709","article-title":"Concurrent infection with multiple human papillomavirus types among unvaccinated and vaccinated 17-year-old Norwegian girls","volume":"226","author":"Laake","year":"2020","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"101593","DOI":"10.1016\/j.canep.2019.101593","article-title":"Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg","volume":"63","author":"Latsuzbaia","year":"2019","journal-title":"Cancer Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"e8516","DOI":"10.7717\/peerj.8516","article-title":"HPV vaccination and sexual behaviour in healthcare seeking young women in Luxembourg","volume":"8","author":"Soudeyns","year":"2020","journal-title":"PeerJ"},{"issue":"13","key":"10.1002\/14651858.CD015363.pub2-BIB0184|cit184","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.vaccine.2022.02.042","article-title":"Long-term effectiveness of human papillomavirus vaccines among adult women: a real-world scenario","volume":"40","author":"Lee Ga","year":"2022","journal-title":"Vaccine"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/infdis\/jix415","article-title":"Human papillomavirus (HPV) prevalence in male adolescents 4 years after HPV-16\/18 vaccination","volume":"216","author":"Lehtinen","year":"2017","journal-title":"Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"e015867","DOI":"10.1136\/bmjopen-2017-015867","article-title":"Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point - registry-based follow-up of three cohorts from randomized trials","volume":"7","author":"Lehtinen","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41416-020-0850-6","article-title":"Impact of HPV vaccination on cervical screening performance: a population-based cohort study","volume":"123","author":"Lei","year":"2020","journal-title":"British Journal of Cancer"},{"issue":"14","key":"10.1002\/14651858.CD015363.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.ogx.0000733532.83957.5b","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"76","author":"Lei","year":"2021","journal-title":"Obstetrical & Gynecological Survey"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/sextrans-2013-051307","article-title":"Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011","volume":"90","author":"Liu","year":"2014","journal-title":"Sexually Transmitted Infections"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0191|cit191","doi-asserted-by":"publisher","first-page":"1204101","DOI":"10.3389\/fpubh.2023.1204101","article-title":"Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017\/2018: results from a nationwide study","volume":"11","author":"Loenenbach","year":"2023","journal-title":"Frontiers in Public Health"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/21645515.2017.1412897","article-title":"Reduction in the burden of hospital admissions due to cervical disease from 2003-2014 in Spain","volume":"14","author":"Lopez","year":"2018","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/OLQ.0000000000001235","article-title":"Impacts of human papillomavirus immunization programs on rates of anogenital warts in British Columbia, Canada, 2000 to 2017","volume":"47","author":"Lukac","year":"2020","journal-title":"Sexually Transmitted Diseases"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0194|cit194","doi-asserted-by":"publisher","first-page":"e050669","DOI":"10.1136\/bmjopen-2021-050669","article-title":"Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial","volume":"11","author":"Lehtinen","year":"2021","journal-title":"BMJ Open"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/ijc.31231","article-title":"Vaccination protects against invasive HPV-associated cancers","volume":"142","author":"Luostarinen","year":"2018","journal-title":"International Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2017.06.001","article-title":"Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure","volume":"146","author":"Lurie","year":"2017","journal-title":"Gynecologic Oncology"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/ijc.33157","article-title":"Prevalence of high-risk human papillomavirus after HPV-vaccination in Denmark","volume":"147","author":"Lynge","year":"2020","journal-title":"International Journal of Cancer"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/jmv.24891","article-title":"Incidence and risk factors for human papillomavirus infections in young female online daters","volume":"89","author":"Ma","year":"2017","journal-title":"Journal of Medical Virology"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/infdis\/jiy075","article-title":"Very low prevalence of vaccine human papillomavirus types among 18- to 35-year old Australian women 9 years following implementation of vaccination","volume":"217","author":"Machalek","year":"2018","journal-title":"Journal of Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/infdis\/jiy684","article-title":"Trends in the prevalence of anogenital warts among patients at sexually transmitted disease clinics - sexually transmitted disease surveillance network, United States, 2010-2016","volume":"219","author":"Mann","year":"2019","journal-title":"Journal of Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/infdis\/jiv342","article-title":"Reduction in human papillomavirus vaccine type prevalence among young women screened for cervical cancer in an integrated US healthcare delivery system in 2007 and 2012-2013","volume":"212","author":"Dunne","year":"2015","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0202|cit202","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/LGT.0000000000000659","article-title":"Changes in cervical cytology results and human papillomavirus types among persons screened for cervical cancer, 2007 and 2015-2017","volume":"26","author":"Lewis","year":"2022","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"29","key":"10.1002\/14651858.CD015363.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1016\/j.vaccine.2019.04.099","article-title":"Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: evidence of direct and herd effects of vaccination","volume":"37","author":"Markowitz","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/infdis\/jiz555","article-title":"Human papillomavirus vaccine effectiveness against HPV infection: evaluation of one, two, and three doses","volume":"221","author":"Markowitz","year":"2020","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0205|cit205","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1158\/1055-9965.EPI-21-0895","article-title":"Impact of a human papillomavirus vaccination program within organized cervical cancer screening: cohort study","volume":"31","author":"Martellucci","year":"2022","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"31","key":"10.1002\/14651858.CD015363.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.vaccine.2021.06.029","article-title":"Papillomavirus vaccination and Guillain-Barre Syndrome among girls: a cohort study in Spain","volume":"39","author":"Martin-Merino","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/jphd.12357","article-title":"Predicted prevalence of oral human papillomavirus (HPV) by periodontitis status and HPV vaccination status","volume":"80","author":"McDaniel","year":"2020","journal-title":"Journal of Public Health Dentistry"},{"issue":"29","key":"10.1002\/14651858.CD015363.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1016\/j.vaccine.2018.05.104","article-title":"Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: the VIP-I study","volume":"36","author":"McGregor","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/ppe.12408","article-title":"The effect of vaccination against human papillomavirus on fecundability","volume":"31","author":"McInerney","year":"2017","journal-title":"Paediatric and Perinatal Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/cid\/ciy1081","article-title":"Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV-16 prevalence in the united kingdom: a cross-sectional study","volume":"69","author":"Mehanna","year":"2019","journal-title":"Clinical Infectious Diseases"},{"issue":"45","key":"10.1002\/14651858.CD015363.pub2-BIB0211|cit211","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1016\/j.vaccine.2023.10.002","article-title":"The impact of over ten years of HPV vaccination in England: surveillance of type-specific HPV in young sexually active females","volume":"41","author":"Checchi","year":"2023","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"e009915","DOI":"10.1136\/bmjopen-2015-009915","article-title":"Continuing reductions in HPV 16\/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study","volume":"6","author":"Mesher","year":"2016","journal-title":"BMJ Open"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/infdis\/jiy249","article-title":"The impact of the national HPV vaccination program in England using the bivalent HPV vaccine: surveillance of type-specific HPV in young females, 2010\u20132016","volume":"218","author":"Mesher","year":"2018","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vaccine.2013.10.085","article-title":"Reduction in HPV 16\/18 prevalence in sexually active young women following the introduction of HPV immunisation in England","volume":"32","author":"Mesher","year":"2013","journal-title":"Vaccine"},{"issue":"36","key":"10.1002\/14651858.CD015363.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.vaccine.2017.06.030","article-title":"Human papillomavirus vaccination and risk of autoimmune diseases: a large cohort study of over 2 million young girls in France","volume":"35","author":"Miranda","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.amepre.2021.06.026","article-title":"High-grade vulvar, vaginal, and anal precancers among U.S. adolescents and young adults after human papillomavirus vaccine introduction","volume":"62","author":"Mix","year":"2022","journal-title":"American Journal of Preventive Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.vaccine.2021.11.062","article-title":"Human papillomavirus vaccines effectiveness to prevent genital warts: a population-based study using health system integrated databases, 2009-2017","volume":"40","author":"Munoz-Quiles","year":"2021","journal-title":"Vaccine"},{"issue":"25","key":"10.1002\/14651858.CD015363.pub2-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/j.vaccine.2017.04.080","article-title":"Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain","volume":"35","author":"Navarro-Illana","year":"2017","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/1471-0528.14563","article-title":"The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study","volume":"124","author":"Munro","year":"2017","journal-title":"BJOG"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0220|cit220","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3390\/ijerph19020693","article-title":"Cervical screening in North Sardinia (Italy): genotype distribution and prevalence of HPV among women with ASC-US cytology","volume":"19","author":"Muresu","year":"2022","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/OLQ.0000000000001103","article-title":"Temporal trends in the incidence of anogenital warts: impact of human papillomavirus vaccination","volume":"47","author":"Naleway","year":"2020","journal-title":"Sexually Transmitted Diseases"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0222|cit222","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/vaccines12020205","article-title":"Genital and oral HPV geno-prevalence measured through urine and saliva samples in young adults in Italy","volume":"12","author":"Napolitano","year":"2024","journal-title":"Vaccines"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0223|cit223","doi-asserted-by":"publisher","first-page":"2392330","DOI":"10.1080\/21645515.2024.2392330","article-title":"Effectiveness of HPV vaccine as part of national immunization program for preventing HPV infection in Thai schoolgirls after seven years post-vaccination","volume":"20","author":"Nilyanimit","year":"2024","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0224|cit224","first-page":"17","article-title":"Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine","volume":"20","author":"Nsouli-Maktabi","year":"2013","journal-title":"MSMR"},{"issue":"37","key":"10.1002\/14651858.CD015363.pub2-BIB0225|cit225","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1016\/j.vaccine.2023.07.031","article-title":"Quadrivalent HPV vaccine effectiveness against anogenital warts: a registry-based study of 2,2 million individuals","volume":"41","author":"Nygard","year":"2023","journal-title":"Vaccine"},{"issue":"1339","key":"10.1002\/14651858.CD015363.pub2-BIB0226|cit226","first-page":"51","article-title":"Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services","volume":"124","author":"Oliphant","year":"2011","journal-title":"New Zealand Medical Journal"},{"issue":"1452","key":"10.1002\/14651858.CD015363.pub2-BIB0227|cit227","first-page":"9","article-title":"Trends in genital warts diagnoses in New Zealand five years following the quadrivalent human papillomavirus vaccine introduction","volume":"130","author":"Oliphant","year":"2017","journal-title":"New Zealand Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0228|cit228","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1111\/cas.15943","article-title":"Human papillomavirus vaccine impact on invasive cervical cancer in Japan: preliminary results from cancer statistics and the MINT study","volume":"114","author":"Onuki","year":"2023","journal-title":"Cancer Science"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0229|cit229","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ijc.34489","article-title":"Real-world effectiveness of HPV vaccination against cervical neoplasia among birth cohorts ineligible for routine vaccination","volume":"153","author":"Dong","year":"2023","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.vaccine.2019.12.016","article-title":"The impact of HPV multi-cohort vaccination: real-world evidence of faster control of HPV-related morbidity","volume":"38","author":"Orumaa","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0231|cit231","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/vaccines12040421","article-title":"Impact of HPV vaccination on the incidence of high-grade cervical intraepithelial neoplasia (CIN2+) in women aged 20\u201325 in the northern part of Norway: a 15-year study","volume":"12","year":"2024","journal-title":"Vaccines"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0232|cit232","doi-asserted-by":"publisher","first-page":"e1202","DOI":"10.1093\/infdis\/jiae209","article-title":"Quadrivalent HPV vaccine effectiveness against cervical intraepithelial lesion grade 2 or worse in Norway: registry-based study of 0,9 million Norwegian women","volume":"230","author":"Orumaa","year":"2024","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0233|cit233","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1186\/s12885-022-10214-1","article-title":"HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis","volume":"22","author":"Osmani","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0234|cit234","doi-asserted-by":"publisher","DOI":"10.1071\/SH22185","article-title":"The effects of bivalent human papillomavirus (HPV) vaccination on high-risk anogenital HPV infection among sexually active female adolescents with and without perinatally acquired HIV","volume":"21","author":"Ounchanum","year":"2024","journal-title":"Sexual Health"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1620\/tjem.240.147","article-title":"Beneficial effects of human papillomavirus vaccine for prevention of cervical abnormalities in Miyagi, Japan","volume":"240","author":"Ozawa","year":"2016","journal-title":"Tohoku Journal of Experimental Medicine"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1620\/tjem.243.329","article-title":"Lower incidence of cervical intraepithelial neoplasia among young women with human papillomavirus vaccination in Miyagi, Japan","volume":"243","author":"Ozawa","year":"2017","journal-title":"Tohoku Journal of Experimental Medicine"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jech-2017-209113","article-title":"The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap","volume":"71","author":"Cameron","year":"2017","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3201\/eid2201.150736","article-title":"Human papillomavirus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009\u20132013","volume":"22","author":"Cameron","year":"2016","journal-title":"Emerging Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/bjc.2016.97","article-title":"Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis","volume":"114","author":"Cuschieri","year":"2016","journal-title":"British Journal of Cancer"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(17)30468-1","article-title":"Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study","volume":"17","author":"Kavanagh","year":"2017","journal-title":"Lancet Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/bjc.2014.198","article-title":"Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16\/18 and closely related HPV types","volume":"110","author":"Kavanagh","year":"2014","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0242|cit242","first-page":"l1161","article-title":"Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study","volume":"365","author":"Palmer","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/bjc.2015.474","article-title":"HPV immunisation and cervical screening -- confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study","volume":"114","author":"Palmer","year":"2016","journal-title":"British Journal of Cancer"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/bjc.2014.479","article-title":"Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland","volume":"111","author":"Pollock","year":"2014","journal-title":"British Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0245|cit245","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/jnci\/djad263","article-title":"Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation","volume":"116","author":"Palmer","year":"2024","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.21873\/invivo.11927","article-title":"Cervical pathology following HPV vaccination in Greece: a 10-year HeCPA observational cohort study","volume":"34","author":"Paraskevaidis","year":"2020","journal-title":"In Vivo"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/OLQ.0000000000000369","article-title":"Trends in male and female genital warts among adolescents in a safety-net health care system 2004-2013: correlation with introduction of female and male human papillomavirus vaccination","volume":"42","author":"Perkins","year":"2015","journal-title":"Sexually Transmitted Diseases"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/OLQ.0000000000000615","article-title":"Impact of number of human papillomavirus vaccine doses on genital warts diagnoses among a national cohort of U.S. adolescents","volume":"44","author":"Perkins","year":"2017","journal-title":"Sexually Transmitted Diseases"},{"issue":"46","key":"10.1002\/14651858.CD015363.pub2-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1016\/j.vaccine.2015.09.071","article-title":"Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: population-based cross-sectional survey of Czech women aged 16 to 40 years","volume":"33","author":"Petras","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"e0201653","DOI":"10.1371\/journal.pone.0201653","article-title":"Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain","volume":"13","author":"Purrinos-Hermida","year":"2018","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/ijc.27971","article-title":"Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: cancer registry-based follow-up","volume":"132","author":"Rana","year":"2013","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0252|cit252","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ygyno.2020.03.030","article-title":"Incidence of vulvar high-grade precancerous lesions and cancer in Denmark before and after introduction of HPV vaccination","volume":"157","author":"Rasmussen","year":"2020","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0253|cit253","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41416-022-01791-w","article-title":"The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot","volume":"127","author":"Rebolj","year":"2022","journal-title":"British Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0254|cit254","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/cancers15051452","article-title":"Impact of preventive strategies on HPV-related diseases: ten-year data from the Italian hospital admission registry","volume":"15","author":"Restivo","year":"2023","journal-title":"Cancers"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0255|cit255","doi-asserted-by":"publisher","first-page":"100798","DOI":"10.1016\/j.lanwpc.2023.100798","article-title":"A single dose of quadrivalent HPV vaccine is highly effective against HPV genotypes 16 and 18 detection in young pregnant women eight years following vaccination: a retrospective cohort study in Fiji","volume":"37","author":"Reyburn","year":"2023","journal-title":"Lancet Regional Health. Western Pacific"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/cncr.32700","article-title":"Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: a database study","volume":"126","author":"Rodriguez","year":"2020","journal-title":"Cancer"},{"issue":"14","key":"10.1002\/14651858.CD015363.pub2-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1002\/cam4.3125","article-title":"Geographical disparities in human papillomavirus herd protection","volume":"9","author":"Berenson","year":"2020","journal-title":"Cancer Medicine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ypmed.2019.03.040","article-title":"Multisite HPV infections in the United States (NHANES 2003-2014): an overview and synthesis","volume":"123","author":"Brouwer","year":"2019","journal-title":"Preventive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-1314-0","article-title":"Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003-2012","volume":"15","author":"Brouwer","year":"2015","journal-title":"BMC Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.2017.75.0141","article-title":"Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States","volume":"36","author":"Chaturvedi","year":"2018","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0261|cit261","doi-asserted-by":"publisher","first-page":"e2238041","DOI":"10.1001\/jamanetworkopen.2022.38041","article-title":"Variation in human papillomavirus vaccination effectiveness in the US by age at vaccination","volume":"5","author":"Egemen","year":"2022","journal-title":"JAMA Network Open"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1080\/21645515.2015.1066948","article-title":"Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years)","volume":"11","author":"Guo","year":"2015","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"50","key":"10.1002\/14651858.CD015363.pub2-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1016\/j.vaccine.2018.10.075","article-title":"Impact of human papillomavirus vaccination on racial\/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.","volume":"36","author":"Hirth","year":"2018","journal-title":"Vaccine"},{"issue":"30","key":"10.1002\/14651858.CD015363.pub2-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1016\/j.vaccine.2019.06.001","article-title":"Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014)","volume":"37","author":"Hirth","year":"2019","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0265|cit265","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1017\/S0950268823000213","article-title":"Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection","volume":"151","author":"Li","year":"2023","journal-title":"Epidemiology and Infection"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010","volume":"208","author":"Markowitz","year":"2013","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"e20151968","DOI":"10.1542\/peds.2015-1968","article-title":"Prevalence of HPV after introduction of the vaccination program in the United States","volume":"137","author":"Markowitz","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/infdis\/jix244","article-title":"Prevalence of human papillomavirus among females after vaccine introduction-national health and nutrition examination survey, United States, 2003-2014","volume":"216","author":"Oliver","year":"2017","journal-title":"Journal of Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"415","DOI":"10.15585\/mmwr.mm7012a2","article-title":"Declines in prevalence of human papillomavirus vaccine-type infection among females after introduction of vaccine - United States, 2003-2018","volume":"70","author":"Rosenblum","year":"2021","journal-title":"MMWR - Morbidity & Mortality Weekly Report"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0270|cit270","doi-asserted-by":"publisher","first-page":"918","DOI":"10.7326\/M21-3798","article-title":"Human papillomavirus vaccine impact and effectiveness through 12 years after vaccine introduction in the United States, 2003 to 2018","volume":"175","author":"Rosenblum","year":"2022","journal-title":"Annals of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0271|cit271","doi-asserted-by":"publisher","first-page":"e222706","DOI":"10.1001\/jamahealthforum.2022.2706","article-title":"Prevalence of human papillomavirus infection among women born in the 1990s vs the 1980s and association with HPV vaccination in the US","volume":"3","author":"Shahmoradi","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"e1918571","DOI":"10.1001\/jamanetworkopen.2019.18571","article-title":"Prevalence of human papillomavirus infection by number of vaccine doses among US women","volume":"2","author":"Sonawane","year":"2019","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0273|cit273","doi-asserted-by":"publisher","first-page":"2308378","DOI":"10.1080\/21645515.2024.2308378","article-title":"High impact of quadrivalent human papillomavirus vaccine across racial\/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018","volume":"20","author":"Stefanos","year":"2024","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/AOG.0000000000001760","article-title":"Prevalence of human papillomavirus in self-collected cervicovaginal swabs in young women in the United States between 2003 and 2012","volume":"128","author":"Tarney","year":"2016","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijgo.2014.03.033","article-title":"Risk perception and sexual behavior in HPV-vaccinated and unvaccinated young Colombian women","volume":"126","author":"Ruiz-Sternberg","year":"2014","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jfprhc-2014-100896","article-title":"Comparing risk behaviours of human papillomavirus-vaccinated and non-vaccinated women","volume":"41","author":"Sadler","year":"2015","journal-title":"Journal of Family Planning and Reproductive Health Care"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0277|cit277","doi-asserted-by":"publisher","first-page":"e29413","DOI":"10.1002\/jmv.29413","article-title":"Effectiveness of prophylactic HPV vaccines against cervical abnormalities and HPV infection in Japan: the J-HERS 2021 multicenter study","volume":"96","author":"Saeki","year":"2024","journal-title":"Journal of Medical Virology"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/LGT.0000000000000564","article-title":"Impact of a high coverage vaccination rate on human papillomavirus infection prevalence in young women: a cross-sectional study","volume":"24","author":"Saldanha","year":"2020","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2340\/00015555-1721","article-title":"A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women--an ecological study","volume":"94","author":"Sando","year":"2014","journal-title":"Acta Dermato-Venereologica"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S1470-2045(21)00453-8","article-title":"Vaccine efficacy against persistent human papillomavirus (HPV) 16\/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study","volume":"22","author":"Basu","year":"2021","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pvr.2019.01.004","article-title":"Two-dose recommendation for human papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort study","volume":"7","author":"Basu","year":"2019","journal-title":"Papillomavirus Research"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0282|cit282","doi-asserted-by":"publisher","first-page":"106244","DOI":"10.1016\/j.oraloncology.2022.106244","article-title":"Impact of HPV vaccination on HPV-related oral infections","volume":"136","author":"Gheit","year":"2023","journal-title":"Oral Oncology"},{"issue":"32 Pt A","key":"10.1002\/14651858.CD015363.pub2-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1016\/j.vaccine.2018.02.087","article-title":"Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study","volume":"36","author":"Sankaranarayanan","year":"2018","journal-title":"Vaccine"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"e02150","DOI":"10.1016\/j.heliyon.2019.e02150","article-title":"Exploration of the effect of human papillomavirus (HPV) vaccination in a cohort of pregnant women in Montreal, 2010-2016","volume":"5","author":"Sarr","year":"2019","journal-title":"Heliyon"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1080\/21645515.2021.1961470","article-title":"Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active women","volume":"17","author":"Sauvageau","year":"2021","journal-title":"Human Vaccines and Immunotherapeutics"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0286|cit286","doi-asserted-by":"publisher","first-page":"e1096","DOI":"10.1016\/S2214-109X(23)00193-6","article-title":"Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys","volume":"11","author":"Sayinzoga","year":"2023","journal-title":"Lancet. Global Health"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0287|cit287","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/1471-0528.17349","article-title":"Spontaneous preterm birth risk among HPV-vaccinated and -unvaccinated women: a nationwide retrospective cohort study of over 240 000 singleton births","volume":"130","author":"McClymont","year":"2023","journal-title":"BJOG"},{"issue":"13","key":"10.1002\/14651858.CD015363.pub2-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa1612296","article-title":"Quadrivalent HPV vaccination and the risk of adverse pregnancy outcomes","volume":"376","author":"Scheller","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0289|cit289","doi-asserted-by":"crossref","first-page":"e37419","DOI":"10.1371\/journal.pone.0037419","article-title":"Cervical, anal and oral HPV in an adolescent inner-city health clinic providing free vaccinations","volume":"7","author":"Schlecht","year":"2012","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/infdis\/jiw486","article-title":"Risk of delayed human papillomavirus vaccination in inner-city adolescent women","volume":"214","author":"Schlecht","year":"2016","journal-title":"Journal of Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"e1914031","DOI":"10.1001\/jamanetworkopen.2019.14031","article-title":"Risk of oral human papillomavirus infection among sexually active female adolescents receiving the quadrivalent vaccine","volume":"2","author":"Schlecht","year":"2019","journal-title":"JAMA Network Open"},{"issue":"24","key":"10.1002\/14651858.CD015363.pub2-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/j.vaccine.2020.03.035","article-title":"No association between HPV vaccination and infertility in U.S. females 18-33 years old","volume":"38","author":"Schmuhl","year":"2020","journal-title":"Vaccine"},{"issue":"45","key":"10.1002\/14651858.CD015363.pub2-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1016\/j.vaccine.2018.09.019","article-title":"No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls","volume":"36","author":"Schurink-Van't Klooster","year":"2018","journal-title":"Vaccine"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0294|cit294","doi-asserted-by":"publisher","first-page":"11786","DOI":"10.1002\/cam4.5842","article-title":"Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands","volume":"12","author":"Schurink-van 't Klooster","year":"2023","journal-title":"Cancer Medicine"},{"issue":"52","key":"10.1002\/14651858.CD015363.pub2-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1016\/j.vaccine.2018.05.048","article-title":"Effectiveness of HPV vaccination against high grade cervical lesions in Japan","volume":"36","author":"Konno","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1186\/s12879-020-05513-6","article-title":"Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women","volume":"20","author":"Shiko","year":"2020","journal-title":"BMC Infectious Diseases"},{"issue":"34","key":"10.1002\/14651858.CD015363.pub2-BIB0297|cit297","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1016\/j.vaccine.2021.07.005","article-title":"Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction","volume":"39","author":"Shilling","year":"2021","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0298|cit298","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pvr.2019.04.007","article-title":"Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: the impact of human papillomavirus vaccination","volume":"7","author":"Shing","year":"2019","journal-title":"Papillomavirus Research"},{"issue":"29","key":"10.1002\/14651858.CD015363.pub2-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.vaccine.2020.05.004","article-title":"Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women","volume":"38","author":"Silverberg","year":"2020","journal-title":"Vaccine"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2352-4642(18)30220-7","article-title":"Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study","volume":"2","author":"Silverberg","year":"2018","journal-title":"Lancet Child and Adolescent Health"},{"issue":"39","key":"10.1002\/14651858.CD015363.pub2-BIB0301|cit301","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1016\/j.vaccine.2018.06.074","article-title":"The association of adverse events with bivalent human papilloma virus vaccination: a nationwide register-based cohort study in Finland","volume":"36","author":"Skufca","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"E74","DOI":"10.1503\/cmaj.140900","article-title":"Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study","volume":"187","author":"Smith","year":"2015","journal-title":"CMAJ: Canadian Medical Association Journal"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"e1131","DOI":"10.1542\/peds.2014-2961","article-title":"The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts","volume":"135","author":"Smith","year":"2015","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0304|cit304","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/tropicalmed9040079","article-title":"Sustained decline in hospitalisations for anogenital warts in Australia: analysis of national hospital morbidity data 2003\u20132020 +","volume":"9","author":"Rashid","year":"2024","journal-title":"Tropical Medicine and Infectious Disease"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0305|cit305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/infdis\/jiu370","article-title":"Fall in genital warts diagnoses in the general and Indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data","volume":"211","author":"Smith","year":"2015","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12879-016-1347-z","article-title":"Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data","volume":"16","author":"Smith","year":"2016","journal-title":"BMC Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1158\/1055-9965.EPI-14-0687","article-title":"Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring study","volume":"23","author":"Soderlund-Strand","year":"2014","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0308|cit308","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/sextrans-2018-053786","article-title":"Epidemiology of genital warts in the British population: implications for HPV vaccination programmes","volume":"95","author":"Sonnenberg","year":"2019","journal-title":"Sexually Transmitted Infections"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0309|cit309","doi-asserted-by":"crossref","first-page":"e20181902","DOI":"10.1542\/peds.2018-1902","article-title":"Human papillomavirus vaccine effectiveness and herd protection in young women","volume":"143","author":"Spinner","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0310|cit310","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/jmv.24968","article-title":"The early impact of human papillomavirus vaccination on anogenital warts in Quebec, Canada","volume":"90","author":"Steben","year":"2018","journal-title":"Journal of Medical Virology"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1071\/SH20033","article-title":"Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian females","volume":"17","author":"Subasinghe","year":"2020","journal-title":"Sexual Health"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0312|cit312","first-page":"S155-","article-title":"Prevention of anal condyloma with quadrivalent human papillomavirus vaccination of older men who have sex with men: a nonconcurrent cohort study","volume":"28","author":"Swedish","year":"2013","journal-title":"Journal of General Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program","volume":"206","author":"Tabrizi","year":"2012","journal-title":"Journal of Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0314|cit314","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1473-3099(14)70841-2","article-title":"Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study","volume":"14","author":"Tabrizi","year":"2014","journal-title":"Lancet Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/jog.13419","article-title":"Preventive effect of human papillomavirus vaccination on the development of uterine cervical lesions in young Japanese women","volume":"43","author":"Tanaka","year":"2017","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"32","key":"10.1002\/14651858.CD015363.pub2-BIB0316|cit316","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/j.vaccine.2019.06.064","article-title":"Cervical cancer screening rate differs by HPV vaccination status: an interim analysis","volume":"37","author":"Taniguchi","year":"2019","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0317|cit317","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pvr.2017.01.001","article-title":"Human papillomavirus (HPV) in young women in Britain: population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types","volume":"3","author":"Tanton","year":"2017","journal-title":"Papillomavirus Research"},{"issue":"351","key":"10.1002\/14651858.CD015363.pub2-BIB0318|cit318","first-page":"33","article-title":"Fertility functions in 4vHPV vaccinated Armenian cohort","volume":"351","author":"Ter-Minasyan","year":"2024","journal-title":"Georgian Medical News"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0319|cit319","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/aogs.13935","article-title":"High-grade cervical lesions after vaccination against human papillomavirus: a Danish cohort study","volume":"99","author":"Thamsborg","year":"2020","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0320|cit320","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/ijc.31568","article-title":"Impact of HPV vaccination on outcome of cervical cytology screening in Denmark-A register-based cohort study","volume":"143","author":"Thamsborg","year":"2018","journal-title":"International Journal of Cancer"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0321|cit321","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12889-016-2885-4","article-title":"Increasing incidence of anogenital warts with an urban-rural divide among males in Manitoba, Canada, 1990-2011","volume":"16","author":"Thompson","year":"2016","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0322|cit322","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/aje\/kwz284","article-title":"Hospital records of pain, fatigue, or circulatory symptoms in girls exposed to human papillomavirus vaccination: cohort, self-controlled case series, and population time trend studies","volume":"189","author":"Thomsen","year":"2020","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0323|cit323","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/OLQ.0b013e3182756efd","article-title":"Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany \u2013 an ecologic study","volume":"40","author":"Mikolajczyk","year":"2013","journal-title":"Sexually Transmitted Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12879-017-2663-7","article-title":"Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine \u2013 an interrupted time series analysis from 2005 to 2010 using health insurance data","volume":"17","author":"Th\u00f6ne","year":"2017","journal-title":"BMC Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0325|cit325","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/21645515.2020.1817715","article-title":"Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study","volume":"17","author":"Tozawa-Ono","year":"2021","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"49","key":"10.1002\/14651858.CD015363.pub2-BIB0326|cit326","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.1016\/j.vaccine.2023.11.010","article-title":"Adverse events from HPV vaccination in Taiwan","volume":"41","author":"Tsai","year":"2023","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0327|cit327","doi-asserted-by":"crossref","first-page":"200233","DOI":"10.1016\/j.tvr.2021.200233","article-title":"The association between viral load and concurrent human papillomavirus infection at the genital and anal sites of young women and the impact of vaccination","volume":"13","author":"Van Eer","year":"2021","journal-title":"Tumour Virus Research"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/cid\/ciz239","article-title":"Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: a Danish nationwide cohort study","volume":"70","author":"Verdoodt","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0329|cit329","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14740338.2020.1688299","article-title":"Hazard of complex regional pain syndrome following human papillomavirus vaccination among adolescent girls in the United States: a case-cohort analysis of insurance claims data","volume":"19","author":"Vielot","year":"2020","journal-title":"Expert Opinion on Drug Safety"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0330|cit330","doi-asserted-by":"crossref","unstructured":"Ward IL Bermingham CR Soldan K Nafilyan V Evaluating the effectiveness of the HPV vaccination programme in England, using regression discontinuity design MedRxiv: the Preprint Server for Health Sciences 2024 10.1101\/2024.04.19.24306076","DOI":"10.1101\/2024.04.19.24306076"},{"issue":"13","key":"10.1002\/14651858.CD015363.pub2-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.vaccine.2021.02.040","article-title":"Effectiveness of a universal vaccination program with an HPV quadrivalent vaccine in young Brazilian women","volume":"39","author":"Wendland","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jadohealth.2018.01.005","article-title":"Epidemiology of any- and vaccine-type anogenital human papillomavirus among 13-26-year-old young men after HPV vaccine introduction","volume":"63","author":"Chandler","year":"2018","journal-title":"Journal of Adolescent Health"},{"issue":"45","key":"10.1002\/14651858.CD015363.pub2-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1016\/j.vaccine.2019.08.052","article-title":"Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction","volume":"37","author":"Widdice","year":"2019","journal-title":"Vaccine"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1080\/21645515.2016.1199308","article-title":"Risk of new onset autoimmune disease in 9-to 25-year-old women exposed to human papillomavirus-16\/18 as04-adjuvanted vaccine in the United Kingdom","volume":"12","author":"Willame","year":"2016","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0335|cit335","doi-asserted-by":"publisher","first-page":"e0267646","DOI":"10.1371\/journal.pone.0267646","article-title":"Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada","volume":"17","author":"Righolt","year":"2022","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0336|cit336","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/OLQ.0000000000000742","article-title":"Early evidence of the effectiveness of the human papillomavirus vaccination program against anogenital warts in Manitoba, Canada: a registry cohort study","volume":"45","author":"Willows","year":"2018","journal-title":"Sexually Transmitted Diseases"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0337|cit337","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/infdis\/jiaa306","article-title":"Vaccine effectiveness against prevalent anal and oral human papillomavirus infection among men who have sex with men - United States, 2016-2018","volume":"222","author":"Meites","year":"2020","journal-title":"Journal of Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0338|cit338","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/OLQ.0000000000001433","article-title":"Sexual positioning practices and anal human papillomavirus infection among young men who have sex with men and transgender women \u2013 Chicago, Illinois, 2016-2018","volume":"48","author":"Morgan","year":"2021","journal-title":"Sexually Transmitted Diseases"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0339|cit339","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/infdis\/jiab390","article-title":"Effectiveness of human papillomavirus (HPV) vaccination against penile HPV infection in men who have sex with men and transgender women","volume":"225","author":"Winer","year":"2021","journal-title":"Journal of Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0340|cit340","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1158\/1055-9965.EPI-19-0618","article-title":"Vaccination of young women decreases human papillomavirus transmission in heterosexual couples: findings from the HITCH cohort study","volume":"28","author":"Wissing","year":"2019","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0341|cit341","first-page":"1280","article-title":"Bivalent vaccine effectiveness against anal human papillomavirus positivity among female sexually transmitted infection clinic visitors in the Netherlands","volume":"221","author":"Woestenberg","year":"2020","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0342|cit342","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/cid\/ciaa582","article-title":"Partial protective effect of bivalent human papillomavirus 16\/18 vaccination against anogenital warts in a large cohort of Dutch primary care patients","volume":"73","author":"Woestenberg","year":"2021","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0343|cit343","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ygyno.2019.02.016","article-title":"HPV infections and cytologic abnormalities in vaccinated women 21-34 years of age: results from the baseline phase of the Onclarity trial","volume":"153","author":"Parvu","year":"2019","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejogrb.2021.05.037","article-title":"Has the human papillomavirus (HPV) immunization programme improved obstetric outcomes in spontaneous delivery? An ecological study","volume":"262","author":"Xu","year":"2021","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"22","key":"10.1002\/14651858.CD015363.pub2-BIB0345|cit345","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.vaccine.2019.04.044","article-title":"Evaluation of future cervical cancer risk in Japan, based on birth year","volume":"37","author":"Yagi","year":"2019","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0346|cit346","first-page":"m4931","article-title":"Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study","volume":"372","author":"Yoon","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0347|cit347","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/LGT.0000000000000401","article-title":"The impact of varying numbers of quadrivalent human papillomavirus vaccine doses on anogenital warts in the united states: a database study","volume":"22","author":"Zeybek","year":"2018","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0348|cit348","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/life13081637","article-title":"Prevalence of high-risk HPV subtypes and efficacy of the HPV vaccine in preventing cervical epithelial lesions: survey and insights from a German study","volume":"13","author":"Abbas","year":"2023","journal-title":"Life (Basel, Switzerland)"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0349|cit349","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3892\/ol.2022.13592","article-title":"Distribution and incidence of atypical glandular lesions in cervical cytology focusing on the association with high-risk human papillomavirus subtypes","volume":"25","author":"Abbas","year":"2023","journal-title":"Oncology Letters"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0350|cit350","first-page":"704","article-title":"Colposcopic performance in a birth cohort previously eligible for \"Human Papillomavirus\" vaccination","volume":"226","author":"Ai Sahlgren","year":"2021","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0351|cit351","doi-asserted-by":"publisher","first-page":"2073750","DOI":"10.1080\/21645515.2022.2073750","article-title":"Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study","volume":"18","author":"Amend","year":"2022","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0352|cit352","doi-asserted-by":"publisher","first-page":"2315653","DOI":"10.1080\/21645515.2024.2315653","article-title":"Real-world data of China: analysis of HPV vaccine coverage and post-vaccination adverse reaction monitoring in Western Chinese provinces from 2018 to 2021","volume":"20","author":"An","year":"2024","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0353|cit353","first-page":"17","article-title":"The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece)","volume":"46","author":"Ansstasiou-Fotaki","year":"2007","journal-title":"Akusherstvo I Ginekologiia"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0354|cit354","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2458-14-155","article-title":"No difference in sexual behavior of adolescent girls following Human Papilloma Virus vaccination: a case study two districts in Uganda; Nakasongola and Luwero","volume":"14","author":"Aujo","year":"2014","journal-title":"BMC Public Health"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015363.pub2-BIB0355|cit355","doi-asserted-by":"publisher","first-page":"A93","DOI":"10.1136\/sextrans-ICAR-2024.85","article-title":"Evolution of anal HPV infection and HPV-related squamous intraepithelial lesions in a cohort of PLWH: is there a benefit of HPV vaccination?","volume":"100","author":"Bailoni","year":"2024","journal-title":"Sexually Transmitted Infections"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0356|cit356","first-page":"201","article-title":"Scottish screening: no cases of invasive cervical cancer in women who received at least one dose of bivalent HPV vaccine at 12 or 13 years of age","volume":"110","author":"Barry","year":"2024","journal-title":"American Family Physician"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0357|cit357","first-page":"38","article-title":"Papillomavirus vaccines: adverse effects","volume":"34","author":"Bayes","year":"2011","journal-title":"Revista de Enfermeria (Barcelona, Spain)"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD015363.pub2-BIB0358|cit358","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/LGT.0000000000000670","article-title":"HPV-associated anal intraepithelial neoplasia in <35-year-old HIV-infected men who have sex with men","volume":"26","author":"Bhardwaj","year":"2022","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0359|cit359","doi-asserted-by":"publisher","first-page":"2289242","DOI":"10.1080\/21645515.2023.2289242","article-title":"Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine","volume":"19","author":"Bhatla","year":"2023","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0360|cit360","first-page":"354","article-title":"Quadrivalent HPV vaccine moderately efficacious in preventing HPV infection and related disease in women aged 24 to 45 years","volume":"16","author":"Block","year":"2009","journal-title":"Journal of Clinical Outcomes Management"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD015363.pub2-BIB0361|cit361","doi-asserted-by":"publisher","first-page":"S733","DOI":"10.1016\/j.ajog.2022.11.1223","article-title":"Safety of the 9-valent HPV vaccine in pregnancy base on adverse events reported in VAERS","volume":"228","author":"Boudova","year":"2023","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0362|cit362","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/OLQ.0000000000000162","article-title":"Human papillomavirus vaccination and cervical cytology in young minority women","volume":"41","author":"Brogly","year":"2014","journal-title":"Sexually Transmitted Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0363|cit363","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1186\/s12889-019-7134-1","article-title":"HPV vaccination has not increased sexual activity or accelerated sexual debut in a college-aged cohort of men and women","volume":"19","author":"Brouwer","year":"2019","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0364|cit364","doi-asserted-by":"publisher","first-page":"e0268104","DOI":"10.1371\/journal.pone.0268104","article-title":"Prevalence and determinants of oral and cervicogenital HPV infection: baseline analysis of the Michigan HPV and Oropharyngeal Cancer (MHOC) cohort study","volume":"17","author":"Brouwer","year":"2022","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0365|cit365","doi-asserted-by":"crossref","first-page":"e056502","DOI":"10.1136\/bmjopen-2021-056502","article-title":"Incidence and clearance of oral and cervicogenital HPV infection: longitudinal analysis of the MHOC cohort study","volume":"12","author":"Brouwer","year":"2022","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0366|cit366","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jpeds.2022.02.036","article-title":"HPV vaccination associated with decreased cervical cancer incidence and mortality","volume":"245","author":"Caskey","year":"2022","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0367|cit367","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pvr.2019.03.001","article-title":"Effect of vaccination against oral HPV-16 infection in high school students in the city of Cali, Colombia","volume":"7","author":"Castillo","year":"2019","journal-title":"Papillomavirus Research"},{"issue":"33","key":"10.1002\/14651858.CD015363.pub2-BIB0368|cit368","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1016\/j.vaccine.2022.06.060","article-title":"Assessment of thyroiditis risk associated with HPV vaccination among girls aged 9-18 years: a time-varying cohort study","volume":"40","author":"Castillo-Cano","year":"2022","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0369|cit369","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/EDE.0000000000001580","article-title":"Self-reported human papillomavirus vaccination and vaccine effectiveness among men who have sex with men: a quantitative bias analysis","volume":"34","author":"Chambers","year":"2023","journal-title":"Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0370|cit370","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2796.2011.02467.x","article-title":"Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine","volume":"271","author":"Chao","year":"2012","journal-title":"Journal of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0371|cit371","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.31557\/APJCP.2024.25.4.1241","article-title":"Prevalence of high-risk HPV detection and HPV vaccination in cervical cancer screening during the HPV vaccination era at Siriraj Hospital \u2013 Thailand's largest national tertiary referral center","volume":"25","author":"Chaopotong","year":"2024","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0372|cit372","doi-asserted-by":"publisher","first-page":"2152256","DOI":"10.1080\/21645515.2022.2152256","article-title":"Real-world safety profile of the 9-valent human papillomavirus vaccine: a study in Zhejiang, China from 2019 to 2021","volume":"18","author":"Chen","year":"2022","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0373|cit373","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1001\/jamaoncol.2022.7944","article-title":"Human papillomavirus vaccination prevalence and disproportionate cancer burden among US veterans","volume":"9","author":"Chidambaram","year":"2023","journal-title":"JAMA Oncology"},{"issue":"Suppl 66","key":"10.1002\/14651858.CD015363.pub2-BIB0374|cit374","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1093\/eurheartj\/ehac544.2494","article-title":"The effects of human papillomavirus vaccination on cardiovascular diseases. The United States National Health and Nutrition Examination Survey","volume":"60","author":"Chou","year":"2022","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0375|cit375","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/head.14458","article-title":"Post-vaccination headache reporting: trends according to the vaccine adverse events reporting system","volume":"63","author":"Cocores","year":"2023","journal-title":"Headache"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD015363.pub2-BIB0376|cit376","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/j.jadohealth.2022.11.165","article-title":"143. Association between number of human papillomavirus (HPV) vaccine doses and detection of vaccine-type HPV and non-vaccine-type HPV genetically related to HPV16 and HPV18 among vaccinated adolescent and young adult women and men in a real-world setting","volume":"72","author":"Craig","year":"2023","journal-title":"Journal of Adolescent Health"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD015363.pub2-BIB0377|cit377","first-page":"S15","article-title":"Prevalence and correlates of high-risk anal human papillomavirus (HPV) infection among men who have sex with men and transgender\/gender non-conforming persons \u2013 New York City sexual health clinics, 2019\u20132020","volume":"49","author":"Crawley","year":"2022","journal-title":"Sexually Transmitted Diseases"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0378|cit378","doi-asserted-by":"publisher","first-page":"100511","DOI":"10.1016\/j.jvacx.2024.100511","article-title":"Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: a 15-year retrospective observational study","volume":"19","author":"Dalla Valle","year":"2024","journal-title":"Vaccine"},{"issue":"14","key":"10.1002\/14651858.CD015363.pub2-BIB0379|cit379","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1016\/j.vaccine.2024.04.033","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine among Alaska Native children aged 9-14 years at 5 years after vaccination","volume":"42","author":"Davis Bionca","year":"2024","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0380|cit380","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jnci\/djaa209","article-title":"Real-world effectiveness of human papillomavirus vaccination against vulvovaginal high-grade precancerous lesions and cancers","volume":"113","author":"Dehlendorff","year":"2021","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0381|cit381","doi-asserted-by":"crossref","unstructured":"Dey A Wang H Quinn H Pillsbury A Hickie M Deng L Surveillance of adverse events following immunisation in Australia annual report, 2020 Communicable Diseases Intelligence (2018) 2022 46 10.33321\/cdi.2022.46.47","DOI":"10.33321\/cdi.2022.46.47"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0382|cit382","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/vaccines10030419","article-title":"Real-life safety profile of the 9-valent HPV vaccine based on data from the Puglia region of Southern Italy","volume":"10","author":"Di Lorenzo","year":"2022","journal-title":"Vaccines"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0383|cit383","doi-asserted-by":"crossref","first-page":"e20191808","DOI":"10.1542\/peds.2019-1808","article-title":"Near real-time surveillance to assess the safety of the 9-valent human papillomavirus vaccine","volume":"144","author":"Donahue","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0384|cit384","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1186\/s12889-018-5745-6","article-title":"Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study","volume":"18","author":"Donken","year":"2018","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0385|cit385","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00404-022-06680-4","article-title":"Regression rate of high-grade cervical intraepithelial lesions in women younger than 25 years","volume":"307","author":"Ehret","year":"2023","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0386|cit386","doi-asserted-by":"publisher","first-page":"2184756","DOI":"10.1080\/21645515.2023.2184756","article-title":"Post-marketing surveillance study of the safety of the HPV-16\/18 vaccine in Korea (2017-2021)","volume":"19","author":"Bahar","year":"2023","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0387|cit387","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1111\/odi.14202","article-title":"Rates of oropharyngeal cancer continue to rise steeply amongst Australian men","volume":"29","author":"Fan","year":"2023","journal-title":"Oral Diseases"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0388|cit388","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/vaccines9040336","article-title":"HPV type-specific prevalence a decade after the implementation of the vaccination program: results from a pilot study","volume":"9","author":"Fappani","year":"2021","journal-title":"Vaccines"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015363.pub2-BIB0389|cit389","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000527858","article-title":"Impact of HPV vaccine on frequency of SIL in screened women in a large academic center (2007-2019): possible herd immunity?","volume":"66","author":"Fatima","year":"2022","journal-title":"Acta Cytologica"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0390|cit390","first-page":"291","article-title":"Sexual risk behaviours and PAP testing in university women vaccinated against human papillomavirus","volume":"50","author":"Fernandez-Feito","year":"2018","journal-title":"Atencion Primaria \/ Sociedad Espanola de Medicina de Familia y Comunitaria"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0391|cit391","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3138\/cjhs.2022-0038","article-title":"HPV unvaccinated status and HPV morbidity risk are common among Canadian university students","volume":"32","author":"Fisher","year":"2023","journal-title":"Canadian Journal of Human Sexuality"},{"issue":"33","key":"10.1002\/14651858.CD015363.pub2-BIB0392|cit392","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1016\/j.vaccine.2012.05.053","article-title":"Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England","volume":"30","author":"Forster","year":"2012","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0393|cit393","doi-asserted-by":"crossref","first-page":"633162","DOI":"10.3389\/fcimb.2021.633162","article-title":"Genotype distribution change after human papillomavirus vaccination in two autonomous communities in Spain","volume":"11","author":"Freire-Salinas","year":"2021","journal-title":"Frontiers in Cellular & Infection Microbiology"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0394|cit394","doi-asserted-by":"crossref","first-page":"100946","DOI":"10.1016\/j.ehb.2020.100946","article-title":"Human papillomavirus vaccine and risky sexual behavior: regression discontinuity design evidence from Brazil","volume":"40","author":"Frio","year":"2021","journal-title":"Economics and Human Biology"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0395|cit395","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11916-022-01094-y","article-title":"Headache after vaccination: an update on recent clinical trials and real-world reporting","volume":"26","author":"Garces","year":"2022","journal-title":"Current Pain and Headache Reports"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0396|cit396","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/vaccines11020284","article-title":"Low-grade cervical intraepithelial neoplasia (CIN1) evolution: analysis of opportunistic preventive vaccination role","volume":"11","author":"Gardella","year":"2023","journal-title":"Vaccines"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0397|cit397","doi-asserted-by":"publisher","first-page":"2105067","DOI":"10.1080\/21645515.2022.2105067","article-title":"Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants","volume":"18","author":"Garland","year":"2022","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"46","key":"10.1002\/14651858.CD015363.pub2-BIB0398|cit398","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1016\/j.vaccine.2011.08.106","article-title":"Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink","volume":"29","author":"Gee","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0399|cit399","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10067-014-2846-1","article-title":"A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events","volume":"34","author":"Geier","year":"2015","journal-title":"Clinical Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0400|cit400","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12026-016-8815-9","article-title":"Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database","volume":"65","author":"Geier","year":"2017","journal-title":"Immunologic Research"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0401|cit401","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12985-023-02270-1","article-title":"Prevalence of high and low risk HPV genotypes among vaccinated and non-vaccinated people in Tehran","volume":"21","author":"Gholamzad","year":"2024","journal-title":"Virology Journal"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0402|cit402","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/pde.15130","article-title":"Incidence of cutaneous warts by HPV vaccination status","volume":"39","author":"Gibson","year":"2022","journal-title":"Pediatric Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0403|cit403","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1007\/s00415-023-11822-y","article-title":"Association between vaccination and the risk of central demyelination: results from a case-referent study","volume":"270","author":"Grimaldi-Bensouda","year":"2023","journal-title":"Journal of Neurology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD015363.pub2-BIB0404|cit404","doi-asserted-by":"publisher","first-page":"S511","DOI":"10.1093\/ofid\/ofad500.982","article-title":"Incidence of adolescent syncope and related injuries following vaccination and routine venipuncture","volume":"10","author":"Groom","year":"2023","journal-title":"Open Forum Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0405|cit405","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365548.2014.964764","article-title":"Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013-2014 after gradual introduction of public HPV vaccination","volume":"47","author":"Grun","year":"2015","journal-title":"Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0406|cit406","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/23744235.2015.1094573","article-title":"Follow-up on oral and cervical human papillomavirus prevalence 2013-2015 in youth at a youth clinic in Stockholm, Sweden","volume":"48","author":"Grun","year":"2016","journal-title":"Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0407|cit407","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1381612826666200212115840","article-title":"Universal human papillomavirus vaccination and its impact on the Southern Italian region","volume":"26","author":"Guido","year":"2020","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0408|cit408","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/ijmm.IJMM_19_427","article-title":"Human papillomavirus infection rates before and after the introduction of prophylactic vaccines in Kunming, Yunnan, China","volume":"38","author":"Guiqian","year":"2020","journal-title":"Indian Journal of Medical Microbiology"},{"issue":"7 Suppl","key":"10.1002\/14651858.CD015363.pub2-BIB0409|cit409","doi-asserted-by":"publisher","first-page":"S456","DOI":"10.1016\/j.jval.2022.04.869","article-title":"EPH118 incidence of human papillomavirus (HPV)-related cancers before and after HPV vaccine introduction among males and females 15-44 years old in the US","volume":"25","author":"Guo","year":"2022","journal-title":"Value in Health"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0410|cit410","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/LGT.0000000000000550","article-title":"HPV catch-up vaccination reduces the prevalence of HPV 16 and 18 infections and cervical disease: a retrospective study","volume":"24","author":"Hallam","year":"2020","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0411|cit411","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/jamaoncol.2016.6192","article-title":"Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: National Health And Nutrition Examination Survey (NHANES) 2013-2014","volume":"3","author":"Han","year":"2017","journal-title":"JAMA Oncology"},{"issue":"39","key":"10.1002\/14651858.CD015363.pub2-BIB0412|cit412","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1016\/j.vaccine.2014.07.025","article-title":"Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: evidence from a large survey of Nordic women","volume":"32","author":"Hansen","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0413|cit413","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.vaccine.2022.11.009","article-title":"Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use","volume":"41","author":"Hansen","year":"2023","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0414|cit414","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3201\/eid2109.141841","article-title":"Monitoring effect of human papillomavirus vaccines in US population, emerging infections program, 2008-2012","volume":"21","author":"Hariri","year":"2015","journal-title":"Emerging Infectious Diseases"},{"issue":"16","key":"10.1002\/14651858.CD015363.pub2-BIB0415|cit415","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cncr.29266","article-title":"Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States","volume":"121","author":"Hariri","year":"2015","journal-title":"Cancer"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0416|cit416","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/heapol\/czaa083","article-title":"Effect of human papilloma virus vaccination on sexual behaviours among adolescent women in Rwanda: a regression discontinuity study","volume":"35","author":"Hategeka","year":"2020","journal-title":"Health Policy and Planning"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0417|cit417","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/vaccines10030387","article-title":"Quadrivalent human papillomavirus vaccine effectiveness after 12 years in Madrid (Spain)","volume":"10","author":"Hernandez-Aguado","year":"2022","journal-title":"Vaccines"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0418|cit418","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciaa1770","article-title":"Population impact of girls-only human papillomavirus 16\/18 vaccination in the Netherlands: cross-protective and second-order herd effects","volume":"72","author":"Hoes","year":"2021","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0419|cit419","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamapediatrics.2015.3926","article-title":"Human papillomavirus vaccination and cervical cytology outcomes among urban low-income minority females","volume":"170","author":"Hofstetter","year":"2016","journal-title":"JAMA Pediatrics"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0420|cit420","doi-asserted-by":"publisher","first-page":"1347800","DOI":"10.3389\/fpubh.2024.1347800","article-title":"Trends of cervical tumours amongst women from perspectives of demographic, socioeconomic and geographic indicators: retrospective ecological study in Czechia","volume":"12","author":"Holy","year":"2024","journal-title":"Frontiers in Public Health"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0421|cit421","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/jmv.21910","article-title":"Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study","volume":"82","author":"Iftner","year":"2010","journal-title":"Journal of Medical Virology"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0422|cit422","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.3390\/vaccines10122113","article-title":"Does vaccination protect against human papillomavirus-related cancers? Preliminary findings from the united states national health and nutrition examination survey (2011-2018)","volume":"10","author":"Issanov","year":"2022","journal-title":"Vaccines"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0423|cit423","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/vaccines12080895","article-title":"Longitudinal screening for oral high-risk non-HPV16 and non-HPV18 strains of human papillomavirus reveals increasing prevalence among adult and pediatric biorepository samples: a pilot study","volume":"12","author":"Jacobs","year":"2024","journal-title":"Vaccines"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0424|cit424","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/aje\/kwz253","article-title":"Effectiveness of 1, 2, and 3 doses of human papillomavirus vaccine against high-grade cervical lesions positive for human papillomavirus 16 or 18","volume":"189","author":"Johnson Jones","year":"2020","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0425|cit425","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.vaccine.2022.11.044","article-title":"Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination","volume":"41","author":"Joshi","year":"2023","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0426|cit426","doi-asserted-by":"publisher","first-page":"111","DOI":"10.15690\/pf.v21i2.2716","article-title":"The state of the reproductive system of adolescent girls after vaccination against human papillomavirus using a quadrivalent vaccine","volume":"21","author":"Karachentsova","year":"2024","journal-title":"Pediatria Farmakologia"},{"issue":"32","key":"10.1002\/14651858.CD015363.pub2-BIB0427|cit427","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1016\/j.vaccine.2023.06.042","article-title":"Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink","volume":"41","author":"Kenigsberg","year":"2023","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0428|cit428","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/sextrans-2020-054428","article-title":"Human papillomavirus (HPV) vaccination and oropharyngeal HPV in ethnically diverse, sexually active adolescents: community-based cross-sectional study","volume":"97","author":"Kerry-Barnard","year":"2021","journal-title":"Sexually Transmitted Infections"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0429|cit429","doi-asserted-by":"publisher","first-page":"e2023064693","DOI":"10.1542\/peds.2023-064693","article-title":"Immunogenicity and safety of extended-interval 2-dose regimens of 9vHPV vaccine","volume":"154","author":"Klein","year":"2024","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0430|cit430","doi-asserted-by":"publisher","first-page":"430.e1","DOI":"10.1016\/j.ajog.2023.11.1235","article-title":"Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study","volume":"230","author":"Krog","year":"2024","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0431|cit431","doi-asserted-by":"publisher","first-page":"898","DOI":"10.4143\/crt.2023.981","article-title":"Predicted cervical cancer prevention: impact of national HPV vaccination program on young women in South Korea","volume":"56","author":"Kwak","year":"2024","journal-title":"Cancer Research and Treatment"},{"issue":"46","key":"10.1002\/14651858.CD015363.pub2-BIB0432|cit432","first-page":"40","article-title":"Bivalent vaccine: real-life data on HPV vaccination","volume":"168","author":"Lang","year":"2023","journal-title":"Pharmazeutische Zeitung"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0433|cit433","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/all.15968","article-title":"Global burden of vaccine-associated anaphylaxis and their related vaccines, 1967-2023: A comprehensive analysis of the international pharmacovigilance database","volume":"79","author":"Lee","year":"2024","journal-title":"Allergy: European Journal of Allergy and Clinical Immunology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD015363.pub2-BIB0434|cit434","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.ijrobp.2024.07.047","article-title":"Incidence of cervical cancer subtypes in relation to HPV vaccination uptake in the U.S.","volume":"120","author":"Lee","year":"2024","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0435|cit435","doi-asserted-by":"publisher","first-page":"e29792","DOI":"10.1002\/jmv.29792","article-title":"Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023: a comprehensive analysis of the international pharmacovigilance database","volume":"96","author":"Lee","year":"2024","journal-title":"Journal of Medical Virology"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0436|cit436","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S1744133119000136","article-title":"HPV vaccine status and sexual behavior among young sexually-active women in the US: evidence from the National Health and Nutrition Examination Survey, 2007-2014","volume":"15","author":"Leidner","year":"2020","journal-title":"Health Economics, Policy, and Law"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0437|cit437","doi-asserted-by":"crossref","unstructured":"Liang X Chou OH Cheung BM The effects of human papillomavirus infection and vaccination on cardiovascular diseases, NHANES 2003-2016 American Journal of Medicine 2023 136 3 294 301 10.1016\/j.amjmed.2022.09.021","DOI":"10.1016\/j.amjmed.2022.09.021"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015363.pub2-BIB0438|cit438","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1016\/S0090-8258%2822%2901600-6","article-title":"Disparities in HPV vaccination in young vs. older Hispanic adults and genital HPV prevalence (378)","volume":"166","author":"Caesar","year":"2022","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0439|cit439","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ijc.34896","article-title":"The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples","volume":"155","author":"Lindquist","year":"2024","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0440|cit440","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/LGT.0000000000000714","article-title":"Factors associated with anal high-grade intraepithelial lesions and carcinoma among young men who have sex with men and transgender women with HIV in Atlanta","volume":"27","author":"Loerinc","year":"2023","journal-title":"Journal of Lower Genital Tract Disease"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0441|cit441","doi-asserted-by":"crossref","first-page":"656.e1","DOI":"10.1016\/j.ajog.2021.07.006","article-title":"Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade >=2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California","volume":"225","author":"Lonky","year":"2021","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0442|cit442","doi-asserted-by":"publisher","first-page":"e0304080","DOI":"10.1371\/journal.pone.0304080","article-title":"Assessing the reduction of viral infectivity in HPV16\/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): study protocol","volume":"19","author":"Lopez-Codony","year":"2024","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0443|cit443","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/ijc.35081","article-title":"Cervical cancer incidence in Denmark: disentangling determinants of time trend","volume":"155","author":"Lynge","year":"2024","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0444|cit444","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.ad.2022.05.020","article-title":"Changes in the prevalence of human papillomavirus genotypes in genital warts since the introduction of prophylactic vaccines","volume":"113","author":"Magdaleno-Tapial","year":"2022","journal-title":"Actas Dermo-Sifiliograficas"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0445|cit445","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1200\/JCO.2013.52.4645","article-title":"Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada","volume":"32","author":"Mahmud","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0446|cit446","doi-asserted-by":"publisher","first-page":"2078626","DOI":"10.1080\/21645515.2022.2078626","article-title":"Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years","volume":"18","author":"Maldonado","year":"2022","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0447|cit447","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.vaccine.2024.02.085","article-title":"Evaluation of the safety profile of the quadrivalent vaccine against human papillomavirus in the risk of developing autoimmune, neurological, and hematological diseases in adolescent women in Colombia","volume":"42","author":"Maldonado","year":"2024","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0448|cit448","doi-asserted-by":"crossref","unstructured":"Man I Georges D Sankaranarayanan R Basu P Baussano I Building resilient cervical cancer prevention through gender-neutral HPV vaccination MedRxiv: the Preprint Server for Health Sciences 2023 10.1101\/2023.01.17.23284655","DOI":"10.1101\/2023.01.17.23284655"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0449|cit449","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s10900-013-9710-0","article-title":"HPV vaccination and sexual behavior in a community college sample","volume":"38","author":"Marchand","year":"2013","journal-title":"Journal of Community Health"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0450|cit450","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/jjco\/hyu097","article-title":"Monitoring the impact of a national HPV vaccination program in Japan (MINT Study): rationale, design and methods","volume":"44","author":"Matsumoto","year":"2014","journal-title":"Japanese Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0451|cit451","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/ijc.30855","article-title":"Early impact of the Japanese immunization program implemented before the HPV vaccination crisis","volume":"141","author":"Matsumoto","year":"2017","journal-title":"International Journal of Cancer"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0452|cit452","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1111\/cas.14212","article-title":"Reduction in HPV16\/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program","volume":"110","author":"Matsumoto","year":"2019","journal-title":"Cancer Science"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0453|cit453","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/1574887118666230410093715","article-title":"Investigating the efficacy of HPV vaccines in preventing cervical cancer from 2006 to 2018 in the US: a SEER data set analysis","volume":"18","author":"Mattis","year":"2023","journal-title":"Reviews on Recent Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0454|cit454","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1055-9965.EPI-18-0885","article-title":"Trends in human papillomavirus vaccine types 16 and 18 in cervical precancers, 2008-2014","volume":"28","author":"McClung","year":"2019","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0455|cit455","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/jog.15530","article-title":"Trends in HPV infection rates and changes in HPV infection type profiles","volume":"49","author":"Megumi","year":"2023","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0456|cit456","doi-asserted-by":"publisher","first-page":"102921","DOI":"10.1016\/j.jaut.2022.102921","article-title":"Autoimmunity in patients reporting long-term complications after exposure to human papillomavirus vaccination","volume":"133","author":"Mehlsen","year":"2022","journal-title":"Journal of Autoimmunity"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0457|cit457","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/14760584.2023.2239911","article-title":"Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in China","volume":"22","author":"Meng","year":"2023","journal-title":"Expert Review of Vaccines"},{"issue":"30","key":"10.1002\/14651858.CD015363.pub2-BIB0458|cit458","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1016\/j.vaccine.2021.05.018","article-title":"Post-vaccination HPV seroprevalence among female sexual health clinic attenders in England","volume":"39","author":"Mesher","year":"2021","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD015363.pub2-BIB0459|cit459","doi-asserted-by":"publisher","first-page":"119282","DOI":"10.1016\/j.cca.2024.119282","article-title":"Real-world data shows the effectiveness of a tetravalent vaccine against human papilloma virus types 16 and 18 in Chilean women","volume":"558","author":"Miranda","year":"2024","journal-title":"Clinica Chimica Acta; International Journal of Clinical Chemistry"},{"issue":"19","key":"10.1002\/14651858.CD015363.pub2-BIB0460|cit460","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1002\/cncr.33582","article-title":"Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States","volume":"127","author":"Mix","year":"2021","journal-title":"Cancer"},{"issue":"16","key":"10.1002\/14651858.CD015363.pub2-BIB0461|cit461","doi-asserted-by":"publisher","first-page":"e70148","DOI":"10.1002\/cam4.70148","article-title":"Prevalence and genotype distribution of HPV combined with cervical pathological results in women from Sichuan, China: a cross-sectional study based on post-vaccination period 2019 to 2023","volume":"13","author":"Mo","year":"2024","journal-title":"Cancer Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0462|cit462","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/23744235.2023.2277390","article-title":"Serologic response to human papillomavirus genotypes following vaccination: findings from the HITCH cohort study","volume":"56","author":"Morais","year":"2024","journal-title":"Infectious Diseases (London, England)"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0463|cit463","doi-asserted-by":"publisher","first-page":"949\u201356","DOI":"10.1093\/infdis\/jiae068","article-title":"Prevalence of human papillomavirus (HPV) and HPV type distribution in penile samples in young men in Denmark: results 10 years after implementation of a girls-only HPV vaccination program","volume":"230","author":"Munk","year":"2024","journal-title":"Journal of Infectious Diseases"},{"issue":"51","key":"10.1002\/14651858.CD015363.pub2-BIB0464|cit464","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1016\/j.vaccine.2020.10.078","article-title":"HPV cervical infections and serological status in vaccinated and unvaccinated women","volume":"38","author":"Murall","year":"2020","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0465|cit465","doi-asserted-by":"publisher","first-page":"e997","DOI":"10.1016\/S2214-109X%2823%2900203-6","article-title":"Impact of the human papillomavirus vaccine in low-resource settings","volume":"11","author":"Murenzi","year":"2023","journal-title":"Lancet Global Health"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0466|cit466","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.3802\/jgo.2024.35.e56","article-title":"HPV vaccination status and effectiveness in Korean women with HPV16\/18 infection (2010-2021): a retrospective study","volume":"35","author":"Na","year":"2024","journal-title":"Journal of Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0467|cit467","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-9378-9-29","article-title":"The levels of anti-HPV16\/18 and anti-HPV31\/33\/35\/45\/52\/58 antibodies among AS04-adjuvanted HPV16\/18 vaccinated and non-vaccinated Ugandan girls aged 10-16 years","volume":"9","author":"Nakalembe","year":"2014","journal-title":"Infectious Agents and Cancer"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0468|cit468","doi-asserted-by":"publisher","first-page":"75","DOI":"10.7812\/TPP\/22.170","article-title":"Epidemiology of upper limb complex regional pain syndrome in a retrospective cohort of persons aged 9-30 years, 2002-2017","volume":"27","author":"Naleway","year":"2023","journal-title":"Permanente Journal"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0469|cit469","first-page":"1436","article-title":"Seroprevalence of HPV infection and its association with HPV vaccination in adolescent girls in suburbs of Hyderabad","volume":"13","author":"Nasreen","year":"2023","journal-title":"European Journal of Cardiovascular Medicine"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0470|cit470","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/cid\/cix455","article-title":"Declines in human papillomavirus (HPV)-associated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, United States, 2008-2015","volume":"65","author":"Niccolai","year":"2017","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0471|cit471","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpag.2023.01.164","article-title":"HPV vaccination: does it increase teen sex?","volume":"36","author":"Ntanika","year":"2023","journal-title":"Journal of Pediatric and Adolescent Gynecology"},{"issue":"41","key":"10.1002\/14651858.CD015363.pub2-BIB0472|cit472","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1503\/cmaj.180628","article-title":"Research Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003-2013)","volume":"190","author":"Ogilvie","year":"2018","journal-title":"CMAJ: Canadian Medical Association Journal"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0473|cit473","doi-asserted-by":"publisher","first-page":"e15294","DOI":"10.1111\/1756-185X.15294","article-title":"Global burden of vaccine-associated rheumatic diseases and their related vaccines, 1967-2023: a comprehensive analysis of the international pharmacovigilance database","volume":"27","author":"Oh","year":"2024","journal-title":"International Journal of Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0474|cit474","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/cas.15270","article-title":"Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women","volume":"113","author":"Onuki","year":"2022","journal-title":"Cancer Science"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0475|cit475","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/vaccines10020188","article-title":"Changes in HPV16\/18 prevalence among unvaccinated women with cervical intraepithelial neoplasia in Japan: assessment of herd effects following the HPV vaccination program","volume":"10","author":"Onuki","year":"2022","journal-title":"Vaccines"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0476|cit476","unstructured":"Paavonen J HPV-16\/18 vaccine is highly effective in preventing precancerous cervical lesions American Journal of Hematology\/Oncology 2009 8 11"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0477|cit477","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.vaccine.2022.01.041","article-title":"Binding antibody levels to vaccine (HPV6\/11\/16\/18) and non-vaccine (HPV31\/33\/45\/52\/58) HPV antigens up to 7 years following immunization with either Cervarix R or Gardasil R vaccine","volume":"40","author":"Panwar","year":"2022","journal-title":"Vaccine"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD015363.pub2-BIB0478|cit478","first-page":"S125","article-title":"Impact of vaccination on the circulation of different human papillomavirus genotypes in male university students from Rio de Janeiro, Brazil","volume":"49","author":"Passos","year":"2022","journal-title":"Sexually Transmitted Diseases"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0479|cit479","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/v16040642","article-title":"Monitoring HPV prevalence and risk cofactors for abnormal cytology in the post-vaccination period among Croatian women","volume":"16","author":"Pesut","year":"2024","journal-title":"Viruses"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0480|cit480","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2334-13-135","article-title":"Prevalence of high-risk HPV types and associated genital diseases in women born in 1988\/89 or 1983\/84 - results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany","volume":"13","author":"Petry","year":"2013","journal-title":"BMC Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0481|cit481","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.chom.2023.10.001","article-title":"Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts","volume":"31","author":"Pimenoff Ville","year":"2023","journal-title":"Cell Host & Microbe"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0482|cit482","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vaccine.2012.10.092","article-title":"Impact of human papillomavirus (HPV) vaccination on HPV 16\/18-related prevalence in precancerous cervical lesions","volume":"31","author":"Powell","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0483|cit483","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12985-024-02413-y","article-title":"The prevalence and genotype distribution of high-risk human papillomaviruses among women in Xianning, China","volume":"21","author":"Qiu","year":"2024","journal-title":"Virology Journal"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0484|cit484","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1017\/S0950268822000619","article-title":"Human papillomavirus prevalence in male and female university students in Gaborone, Botswana","volume":"150","author":"Ramogola-Masire","year":"2022","journal-title":"Epidemiology and Infection"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0485|cit485","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1059840513520042","article-title":"Human papillomavirus vaccine increases high-risk sexual behaviors: a myth or valid concern","volume":"30","author":"Ratanasiripong","year":"2014","journal-title":"Journal of School Nursing"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0486|cit486","doi-asserted-by":"publisher","first-page":"e2022060993","DOI":"10.1542\/PEDS.2022-060993","article-title":"Ten-year follow-up of 9-valent human papillomavirus vaccine: immunogenicity, effectiveness, and safety","volume":"152","author":"Restrepo","year":"2023","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0487|cit487","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ijc.32135","article-title":"Effectiveness of school-based and high-risk human papillomavirus vaccination programs against cervical dysplasia in Manitoba, Canada","volume":"145","author":"Righolt","year":"2019","journal-title":"International Journal of Cancer"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0488|cit488","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s10096-024-04887-8","article-title":"Oral HPV infection clearance and acquisition after nonavalent vaccination in men who have sex with men and transgender women: a prospective analysis","volume":"43","author":"Rossotti","year":"2024","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0489|cit489","doi-asserted-by":"publisher","first-page":"215013192211104","DOI":"10.1177\/21501319221110411","article-title":"Human papillomavirus prevalence and vaccination rates among users of pre-exposure prophylaxis for human immunodeficiency virus prevention","volume":"13","author":"Rotert","year":"2022","journal-title":"Journal of Primary Care & Community Health"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0490|cit490","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s11845-023-03551-y","article-title":"The effect of HPV vaccination on the rate of high-grade cytology in 25-year-old women attending cervical screening in Ireland","volume":"193","author":"Rourke","year":"2024","journal-title":"Irish Journal of Medical Science"},{"issue":"43","key":"10.1002\/14651858.CD015363.pub2-BIB0491|cit491","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1016\/j.vaccine.2019.08.058","article-title":"Prevalence of oral human papillomavirus infection among university students in Valencia, Spain","volume":"37","author":"Sastre-Canton","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0492|cit492","doi-asserted-by":"publisher","first-page":"681","DOI":"10.31557\/APJCP.2024.25.2.681","article-title":"Vaccination effectiveness against human papillomavirus in Kazakhstan","volume":"25","author":"Satanova","year":"2024","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0493|cit493","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.vaccine.2022.10.050","article-title":"Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United States","volume":"41","author":"Seeger","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0494|cit494","first-page":"22","article-title":"Effect of prophylactic vaccination against HPV infection on the incidence of cervical precancers and cancers","volume":"16","author":"Sehnal","year":"2022","journal-title":"Vakcinologie"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0495|cit495","doi-asserted-by":"publisher","first-page":"7342061","DOI":"10.1155\/2022\/7342061","article-title":"Outcomes of human papilloma virus vaccination in a private women health clinic in Lebanon","volume":"2022","author":"Seoud","year":"2022","journal-title":"Obstetrics and Gynecology International"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0496|cit496","doi-asserted-by":"publisher","first-page":"e2024037","DOI":"10.23750\/abm.v95i3.15352","article-title":"Prevalence of hr-HPV genotypes among vaccinated and unvaccinated women in central Italy: a retrospective study","volume":"95","author":"Serafini","year":"2024","journal-title":"Acta Biomedica"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0497|cit497","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1089\/jwh.2022.0456","article-title":"Human papillomavirus vaccination status and correlates among mid-adult women: Connecticut, USA, 2016-2019","volume":"33","author":"Sheth","year":"2024","journal-title":"Journal of Women's Health"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0498|cit498","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1684\/ejd.2022.4326","article-title":"Nonavalent human papillomavirus vaccine for cutaneous warts: a retrospective study","volume":"32","author":"Shin","year":"2022","journal-title":"European Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0499|cit499","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41541-024-00896-y","article-title":"Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial","volume":"9","author":"Shing","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0500|cit500","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1080\/0284186X.2023.2264485","article-title":"Prevalence of human papillomavirus (HPV) types 16 and 18 in cervical cancer in Stockholm, Sweden during 2019-2023 compared to 2003-2008","volume":"62","author":"Sivars","year":"2023","journal-title":"Acta Oncologica"},{"issue":"9907","key":"10.1002\/14651858.CD015363.pub2-BIB0501|cit501","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(13)61947-9","article-title":"Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (NatSAL)","volume":"382","author":"Sonnenberg","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0502|cit502","doi-asserted-by":"publisher","first-page":"1074246","DOI":"10.3389\/fimmu.2023.1074246","article-title":"Allergic adverse events following immunization: data from post-marketing surveillance in Apulia region (South of Italy)","volume":"14","author":"Stefanizzi","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0503|cit503","doi-asserted-by":"publisher","first-page":"2159215","DOI":"10.1080\/21645515.2022.2159215","article-title":"Extended surveillance to assess safety of 9-valent human papillomavirus vaccine","volume":"18","author":"Sundaram","year":"2022","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0504|cit504","first-page":"A5540","article-title":"No effect of human papillomavirus vaccination on sexual debut of school children","volume":"66","author":"Svarrer","year":"2019","journal-title":"Danish Medical Journal"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD015363.pub2-BIB0505|cit505","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/j.jid.2023.03.537","article-title":"531 Prevalence of condyloma acuminata in sexual and gender diverse populations: a retrospective cohort study","volume":"143","author":"Tan","year":"2023","journal-title":"Journal of Investigative Dermatology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD015363.pub2-BIB0506|cit506","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/j.fertnstert.2023.05.107","article-title":"HPV vaccination status among fertility patients: how common is it?","volume":"120","author":"Tarrash","year":"2023","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0507|cit507","first-page":"1","article-title":"Human papillomavirus vaccination and premature ovarian failure: a disproportionality analysis using the vaccine adverse event reporting system","volume":"1","author":"Tatang","year":"2021","journal-title":"Drugs - Real World Outcomes"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0508|cit508","doi-asserted-by":"publisher","first-page":"e2214020","DOI":"10.1001\/jamanetworkopen.2022.14020","article-title":"Test performance of cervical cytology among adults with vs without human papillomavirus vaccination","volume":"5","author":"Teoh","year":"2022","journal-title":"JAMA Network Open"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD015363.pub2-BIB0509|cit509","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/pds.5518","article-title":"Anti-NMDA receptor encephalitis and vaccines","volume":"31","author":"Trenque","year":"2022","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0510|cit510","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41541-022-00431-x","article-title":"HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial","volume":"7","author":"Tsang","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0511|cit511","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1248\/yakushi.22-00142","article-title":"Establishment of mono-scaled benefit\/risk analysis of HPV vaccine","volume":"142","author":"Tsukamoto","year":"2022","journal-title":"Yakugaku Zasshi"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0512|cit512","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s40264-022-01219-7","article-title":"Adverse events following HPV vaccination in the Veneto region: data from spontaneous reporting","volume":"45","author":"Valle","year":"2022","journal-title":"Drug Safety"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0513|cit513","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/infdis\/jiad080","article-title":"Effects of 2 and 3 vaccinations with the bivalent human papillomavirus (HPV) vaccine on the prevalence and load of HPV in clearing and persistent infections in young women","volume":"228","author":"Van Eer","year":"2023","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0514|cit514","doi-asserted-by":"publisher","first-page":"241","DOI":"10.21873\/INVIVO.12697","article-title":"Prevalence and determinants of vaginal infection with human papillomavirus among female university students in Vietnam","volume":"36","author":"Van Trang","year":"2022","journal-title":"In Vivo"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0515|cit515","doi-asserted-by":"publisher","first-page":"200255","DOI":"10.1016\/j.tvr.2023.200255","article-title":"Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening","volume":"15","author":"Velentzis","year":"2023","journal-title":"Tumour Virus Research"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0516|cit516","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13075-024-03296-8","article-title":"Vaccination and the risk of systemic lupus erythematosus: a meta-analysis of observational studies","volume":"26","author":"Wang","year":"2024","journal-title":"Arthritis Research & Therapy"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0517|cit517","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13027-022-00431-5","article-title":"The prevalence and genotype distribution of human papillomavirus among women in Guangxi, southern China","volume":"17","author":"Wei","year":"2022","journal-title":"Infectious Agents and Cancer"},{"issue":"10","key":"10.1002\/14651858.CD015363.pub2-BIB0518|cit518","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/pds.5644","article-title":"A feasibility assessment of real-world data capabilities for monitoring vaccine safety and effectiveness in China: human papillomavirus vaccination in the Yinzhou district as a use case","volume":"32","author":"Welby","year":"2023","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0519|cit519","doi-asserted-by":"publisher","first-page":"2283912","DOI":"10.1080\/21645515.2023.2283912","article-title":"Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16\/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018-2020","volume":"19","author":"Wu","year":"2023","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0520|cit520","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/cas.16055","article-title":"Effectiveness of catch-up and routine program of the 9-valent vaccine on cervical cancer risk reduction in Japan","volume":"115","author":"Yagi","year":"2024","journal-title":"Cancer Science"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0521|cit521","first-page":"718","article-title":"IV. HPV vaccines in head and neck cancer prevention","volume":"51","author":"Yasuda","year":"2024","journal-title":"Gan to Kagaku Ryoho. Cancer & Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD015363.pub2-BIB0522|cit522","doi-asserted-by":"publisher","first-page":"2281700","DOI":"10.1080\/21645515.2023.2281700","article-title":"Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16-26 years in Chongqing, China","volume":"19","author":"Zhang","year":"2023","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0523|cit523","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/vaccines12060673","article-title":"Safety assessment of concurrent vaccination with the HPV vaccine and the COVID-19 vaccine in Fujian Province, China: a retrospective study","volume":"12","author":"Zhang","year":"2024","journal-title":"Vaccines"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0524|cit524","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/ajco.13833","article-title":"Safety of AS04-HPV-16\/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: a 10-year follow-up study","volume":"19","author":"Zhao","year":"2023","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0525|cit525","doi-asserted-by":"publisher","first-page":"634","DOI":"10.7326\/M21-3023","article-title":"Risk for shoulder conditions after vaccination: a population-based study using real-world data","volume":"175","author":"Zheng","year":"2022","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0526|cit526","doi-asserted-by":"crossref","unstructured":"De Kloe J Urdang ZD Martinez Outschoorn UE Curry JM Effects of HPV vaccination on the development of HPV-related cancers: a retrospective analysis of a United States-based cohort Journal of Clinical Oncology 2024 42 16 Suppl","DOI":"10.1200\/JCO.2024.42.16_suppl.10507"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0527|cit527","doi-asserted-by":"crossref","unstructured":"Dominicci-Maura A Ortiz AP Romaguera J Godoy-Vitorino F Prevalence of anal HPV infection in women attending a gynecology and colposcopy clinic: assessing the potential impact of HPV vaccination Cancer Research 2024 84 6 Suppl 10.1158\/1538-7445.AM2024-4804","DOI":"10.1158\/1538-7445.AM2024-4804"},{"issue":"18 Suppl","key":"10.1002\/14651858.CD015363.pub2-BIB0528|cit528","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1212\/WNL.98.18_supplement.3822","article-title":"Guillain-Barr\u00e9 syndrome after HPV vaccination: a report from the Vaccine Adverse Event Reporting System (VAERS) (2006-2021)","volume":"98","author":"Elshourbagy","year":"2022","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0529|cit529","first-page":"e582","article-title":"Benefits of HPV vaccination beyond CDC recommended age remains unclear in the prevention of anal dysplasia in men","volume":"66","author":"Lau","year":"2023","journal-title":"Diseases of the Colon and Rectum"},{"issue":"16 Suppl","key":"10.1002\/14651858.CD015363.pub2-BIB0530|cit530","doi-asserted-by":"publisher","first-page":"10544","DOI":"10.1200\/jco.2023.41.16_suppl.10544","article-title":"The impact of HPV vaccination in Florida compared to New York","volume":"41","author":"Neerukonda","year":"2023","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0531|cit531","unstructured":"Adhanom-Ghebreyesus T Cervical Cancer: An NCD We Can Overcome World Health Organization (WHO) 2018 [cited 19 May 2018]. Available at https:\/\/www.who.int\/dg\/speeches\/detail\/cervical-cancer-an-ncd-we-can-overcome"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0532|cit532","doi-asserted-by":"crossref","first-page":"48","DOI":"10.12688\/wellcomeopenres.15140.1","article-title":"HPV infection and pre-term birth: a data-linkage study using Scottish Health Data","volume":"4","author":"Aldhous","year":"2019","journal-title":"Wellcome Open Research"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0533|cit533","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009069.pub3","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","author":"Arbyn","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0534|cit534","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/qhc.12.6.458","article-title":"Statistical process control as a tool for research and healthcare improvement","volume":"12","author":"Benneyan","year":"2003","journal-title":"Quality & Safety in Health Care"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0535|cit535","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015364.pub2","article-title":"Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis","author":"Bergman","year":"2025","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0536|cit536","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"Journal of Clinical Pathology"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0537|cit537","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: a Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0538|cit538","first-page":"42","article-title":"Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage","volume":"47","author":"Brotherton","year":"2018","journal-title":"Best Practice and Research: Clinical Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0539|cit539","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1467-8519.1989.tb00328.x","article-title":"A report from New Zealand: an 'Unfortunate experiment'","volume":"3","author":"Campbell","year":"1989","journal-title":"Bioethics"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0540|cit540","first-page":"l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0541|cit541","unstructured":"Cancer Research UK Cervical cancer incidence by stage at diagnosis Available at www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/cervical-cancer\/incidence#heading-Three2017"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0542|cit542","unstructured":"Cancer Research UK Cervical cancer statistics Available at www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/cervical-cancer"},{"issue":"10135","key":"10.1002\/14651858.CD015363.pub2-BIB0543|cit543","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(18)30854-7","article-title":"Rapid response to HPV vaccination crisis in Ireland","volume":"391","author":"Corcoran","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0544|cit544","unstructured":"COVID-19 vaccine effectiveness on variants of concern: observational studies Available at https:\/\/covid-nma.com\/vaccines\/os_vaccines\/"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0545|cit545","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12879-018-3582-y","article-title":"Prevalence and incidence of genital warts and cervical human papillomavirus infections in Nigerian women","volume":"19","author":"Dareng","year":"2019","journal-title":"BMC Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0546|cit546","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncology"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0547|cit547","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"De Martel","year":"2017","journal-title":"International Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0548|cit548","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/sti.2010.048421","article-title":"Genital warts and cost of care in England","volume":"87","author":"Desai","year":"2011","journal-title":"Sexually Transmitted Infections"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0549|cit549","unstructured":"DistillerSR. Version 2.35 Evidence Partners 2021"},{"issue":"10197","key":"10.1002\/14651858.CD015363.pub2-BIB0550|cit550","doi-asserted-by":"crossref","first-page":"497\u2013509","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0551|cit551","doi-asserted-by":"crossref","first-page":"2239085","DOI":"10.1080\/21645515.2023.2239085","article-title":"Human papillomavirus vaccine effectiveness by age at vaccination: a systematic review","volume":"19","author":"Ellingson","year":"2023","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"10316","key":"10.1002\/14651858.CD015363.pub2-BIB0552|cit552","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"issue":"15-16","key":"10.1002\/14651858.CD015363.pub2-BIB0553|cit553","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.vaccine.2004.01.017","article-title":"Control without separate controls: evaluation of vaccine safety using case-only methods","volume":"22","author":"Farrington","year":"2004","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0554|cit554","unstructured":"What is a serious adverse event? https:\/\/www.fda.gov\/safety\/reporting-serious-problems-fda\/what-serious-adverse-event"},{"issue":"32","key":"10.1002\/14651858.CD015363.pub2-BIB0555|cit555","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.vaccine.2018.02.003","article-title":"Status of HPV vaccine introduction and barriers to country uptake","volume":"36","author":"Gallagher","year":"2018","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0556|cit556","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2025"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0557|cit557","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0558|cit558","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1743-422X-10-137","article-title":"Detection of specific HPV subtypes responsible for the pathogenesis of condylomata acuminata","volume":"10","author":"Hawkins","year":"2013","journal-title":"Virology Journal"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0559|cit559","volume-title":"Primary End-Points for Prophylactic HPV Vaccine Trials. IARC Working Group Report","author":"International Agency for Research in Cancer","year":"2014"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0560|cit560","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00019053-200523110-00004","article-title":"Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature","volume":"23","author":"Insinga","year":"2005","journal-title":"PharmacoEconomics"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0561|cit561","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/1055-9965.EPI-10-0791","article-title":"Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance","volume":"20","author":"Insinga","year":"2011","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0562|cit562","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0563|cit563","doi-asserted-by":"crossref","first-page":"e79260","DOI":"10.1371\/journal.pone.0079260","article-title":"Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study","volume":"8","author":"Jaisamrarn","year":"2013","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0564|cit564","first-page":"1","article-title":"Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports","volume":"9","author":"J\u00f8rgensen","year":"2020","journal-title":"Systematic Reviews"},{"issue":"7-8","key":"10.1002\/14651858.CD015363.pub2-BIB0565|cit565","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1080\/21645515.2018.1564436","article-title":"HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe","volume":"15","author":"Karafillakis","year":"2019","journal-title":"Human Vaccines and Immunotherapeutics"},{"issue":"24","key":"10.1002\/14651858.CD015363.pub2-BIB0566|cit566","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"10.1002\/14651858.CD015363.pub2-BIB0567|cit567","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008587.pub2","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD015363.pub2-BIB0568|cit568","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012847","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0569|cit569","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijgo.12186","article-title":"Progress in HPV vaccination in low- and lower-middle-income countries","volume":"138","author":"LaMontagne","year":"2017","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"14","key":"10.1002\/14651858.CD015363.pub2-BIB0570|cit570","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"32 Pt A","key":"10.1002\/14651858.CD015363.pub2-BIB0571|cit571","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1016\/j.vaccine.2018.01.057","article-title":"Human papillomavirus vaccine effectiveness by number of doses: systematic review of data from national immunization programs","volume":"36","author":"Markowitz","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0572|cit572","first-page":"451","article-title":"The invasive potential of carcinoma in situ of the cervix","volume":"64","author":"McIndoe","year":"1984","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0573|cit573","unstructured":"Morgan E Written statement: change to cervical screening interval https:\/\/www.gov.wales\/written-statement-change-cervical-screening-interval"},{"issue":"4","key":"10.1002\/14651858.CD015363.pub2-BIB0574|cit574","first-page":"362","article-title":"The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer","volume":"30","author":"Munoz","year":"1996","journal-title":"Bulletin of the Pan American Health Organization"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0575|cit575","unstructured":"NHS Digital Cervical Screening Programme, England - 2019-20: Official statistics, National statistics; November 2020 Available at www.digital.nhs.uk\/data-and-information\/publications\/statistical\/cervical-screening-annual\/england---2019-20"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0576|cit576","unstructured":"NHS Digital Cervical Screening Programme, England - 2019-20: Official statistics, National statistics: Section 3: Colposcopy; November 2020 Available at www.digital.nhs.uk\/data-and-information\/publications\/statistical\/cervical-screening-annual\/england---2019-20\/colposcopy"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0577|cit577","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jclinepi.2021.01.006","article-title":"An evaluation of Cochrane Crowd found that crowdsourcing produced accurate results in identifying randomized trials","volume":"133","author":"Noel-Storr","year":"2021","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0578|cit578","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-13-39","article-title":"Systematic review of the incidence and prevalence of genital warts","volume":"13","author":"Patel","year":"2013","journal-title":"BMC Infectious Diseases"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0579|cit579","first-page":"1","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0580|cit580","unstructured":"Public Health Scotland Scottish Cervical Screening Programme Statistics 2021\/22 Available at https:\/\/publichealthscotland.scot\/publications\/scottish-cervical-screening-programme-statistics\/scottish-cervical-screening-programme-statistics-annual-update-to-31-march-2022\/"},{"issue":"2","key":"10.1002\/14651858.CD015363.pub2-BIB0581|cit581","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jnci\/djz074","article-title":"Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: an interim analysis of a randomized clinical trial","volume":"112","author":"Qiao","year":"2020","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0582|cit582","first-page":"e068776","article-title":"Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data","volume":"377","author":"Rebolj","year":"2022","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0583|cit583","unstructured":"Reeves BC Deeks JJ Higgins JP Shea B Tugwell P Wells GA Chapter 24: Including non-randomized studies on intervention effects. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available at https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0584|cit584","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2025"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0585|cit585","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.01.012","article-title":"GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence","volume":"111","author":"Sch\u00fcnemann","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0586|cit586","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Guyatt GH Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021 Available at https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.2"},{"issue":"5","key":"10.1002\/14651858.CD015363.pub2-BIB0587|cit587","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/sextrans-2018-053786","article-title":"Epidemiology of genital warts in the British population: implications for HPV vaccination programmes","volume":"95","author":"Sonnenberg","year":"2019","journal-title":"Sexually Transmitted Infections"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0588|cit588","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/rmv.498","article-title":"Human papillomavirus vaccines","volume":"16","author":"Stanley","year":"2006","journal-title":"Reviews in Medical Virology"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0589|cit589","first-page":"i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0590|cit590","unstructured":"Sterne JA Hern\u00e1n MA McAleenan A Reeves BC Higgins JP Chapter 25: Assessing risk of bias in a non-randomized study. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021 Available at https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.2"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0591|cit591","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1186\/s12889-018-6268-x","article-title":"Decline in HPV-vaccination uptake in Denmark - the association between HPV-related media coverage and HPV-vaccination","volume":"18","author":"Suppli","year":"2018","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1002\/14651858.CD015363.pub2-BIB0592|cit592","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/ndt\/gfu325","article-title":"Graphical presentation of confounding in directed acyclic graphs","volume":"30","author":"Suttorp","year":"2015","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD015363.pub2-BIB0593|cit593","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.1986333","article-title":"Changing trends in HPV vaccination in Japan","volume":"18","author":"Ujiie","year":"2022","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"12","key":"10.1002\/14651858.CD015363.pub2-BIB0594|cit594","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1080\/14760584.2022.2129615","article-title":"Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review","volume":"21","author":"Wang","year":"2022","journal-title":"Expert Review of Vaccines"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0595|cit595","first-page":"241","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Weekly Epidemiological Record"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0596|cit596","unstructured":"World Health Organization Cervical cancer Available at www.who.int\/cancer\/prevention\/diagnosis-screening\/ cervical-cancer\/en\/"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0597|cit597","unstructured":"World Health Organization Global strategy to accelerate the elimination of cervical cancer as a public health problem Available at https:\/\/www.who.int\/publications\/i\/item\/9789240014107"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0598|cit598","unstructured":"World Health Organization Immunization coverage Available at www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0599|cit599","unstructured":"World Health Organization List of prequalified vaccines Available at www.extranet.who.int\/pqweb\/vaccines\/list-prequalified-vaccines"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0600|cit600","unstructured":"World Health Organization WHO Cervical Cancer Elimination Initiative: from call to action to global movement Available at https:\/\/www.who.int\/publications\/m\/item\/who-cervical-cancer-elimination-initiative--from-call-to-action-to-global-movement"},{"issue":"7","key":"10.1002\/14651858.CD015363.pub2-BIB0601|cit601","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1080\/21645515.2020.1756670","article-title":"Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia","volume":"16","author":"Wong","year":"2020","journal-title":"Human Vaccines and Immunotherapeutics"},{"issue":"6","key":"10.1002\/14651858.CD015363.pub2-BIB0602|cit602","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/sextrans-2011-050073","article-title":"The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK","volume":"87","author":"Woodhall","year":"2011","journal-title":"Sexually Transmitted Infections"},{"key":"10.1002\/14651858.CD015363.pub2-BIB0603|cit603","unstructured":"World Bank Country and Lending Groups Available at datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:53:52Z","timestamp":1790218432000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015363.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":603,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015363.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}